ID;Term;Depth;IC Nuno;IC zhou;IC sanchez;IC resnik;IC RZ;IC Rnormalized;IC Nuno org;Annotated Genes Set number
GO:0036496;regulation of translational initiation by eIF2 alpha dephosphorylation;10.0;0.9326813400603323;0.8815816818910864;9.608321545174602;674.6262540571083;9.083926447120524;0.022579133599080606;0.8797934328124444;[PPP1R15A, PPP1CA]
GO:0006281;DNA repair;7.0;0.6281612110245125;0.6649999707694567;8.781226392104918;180.342582143442;3.582668236575797;0.006035903926554339;0.534137185486798;[USP36, DCLRE1A, FEN1, BTG2, SMG1, WDR48, DCLRE1C, CCNH, UBE2D3, MUM1, BCCIP, CIB1, BRCA1, PARK7, SMC6, YY1, POLB, NIPBL, CHAF1B, CHAF1A, EXO1, EP300, TOPBP1, POLH, RFC5, UPF1, AQR, RFC3, RFC4, FBXO18, DTX3L, RFC1, NCOA6, PARP2, RFC2, NSMCE2, RAD23A, DDB1, NEIL3, RAD51C, MSH3, TIMELESS, PCNA, PAXIP1, PNKP, GPS1, COPS7B, COPS7A, XPC, UNG, RAD51AP1, TFPT, FZR1, WRN, POLR2B, RNF138, RAD21, UBR5, ABL1, POLR2E, RAD54L, POLR2G, USP51, POLR2I, POLR2K, FANCI, POLQ, XRCC6, UBE2B, EYA2, XRCC5, FANCL, INTS3, NONO, GINS4, APEX2, CDC5L, CDC7, FANCE, GTF2H4, SETX, CDK9, SMUG1, HIST3H2A, COPS5, RAD51, NPLOC4, TTC5, UBE2T, POLE2, RFWD3, CDK2, ERCC5, MNAT1]
GO:0036499;PERK-mediated unfolded protein response;6.0;1.0;0.8231203125901445;9.628524252492122;80.02054155744251;7.292166977892469;0.0026782155121157316;0.6960420709600095;[EIF2AK3, CCL2, EIF2S1, ATF4]
GO:1901224;positive regulation of NIK/NF-kappaB signaling;8.0;0.9326813400603323;0.8413406700301662;9.571365838652174;238.82315740091596;5.572381008289503;0.007993196151321231;0.6599718239061428;[TNFSF14, SPHK1, ZFP91, TNFRSF10B, TNFRSF10A, AGER, RELA, RC3H2, NLRP12, IL23A, TLR7, CCL19, SASH1, LIMS1, HAVCR2]
GO:0045766;positive regulation of angiogenesis;7.0;0.811012628672052;0.7564256795932265;9.303101852057495;134.49314513679974;4.7081694254602375;0.0045013645317563845;0.5916953686275062;[ITGB1, CD40, BTG1, PDCD6, ITGB2, CIB1, BRCA1, THBS1, MTDH, AQP1, C3, RRAS, TBXA2R, ABL1, CTSH, SASH1, MAP3K3, XBP1, ANXA1, JUP, SPHK1, RHOB, RUNX1, PDCL3, SFRP2, SP1, TEK, EPHA1]
GO:0007259;JAK-STAT cascade;7.0;0.9326813400603323;0.8172600352873667;9.510741216835738;26.42836680105094;6.221725566191056;8.845336528452411E-4;0.6690987000520388;[IFNAR2, CCL2, PKD2, CCR2]
GO:0000187;activation of MAPK activity;13.0;0.811012628672052;0.8680612791036626;9.526741558182179;3706.2450018205795;4.759793790865545;0.12404468480698592;0.705971040585548;[DUSP5, MAP4K2, CD74, DBNL, PDE6H, SYK, THBS1, MAPK8IP3, SOD1, ERN1, P2RX7, KARS, TAOK2, KIT, MADD, RIPK1, CCL19, MAP3K5]
GO:0002358;B cell homeostatic proliferation;7.0;1.0;0.8509193652572005;9.628524252492122;51.699941136945895;9.083926447120524;0.0017303505029273396;0.8154717862087246;[BAX]
GO:0048247;lymphocyte chemotaxis;7.0;0.7671156992804218;0.7344772148974115;9.303101852057495;94.37808318069546;5.926926025970411;0.003158749509297446;0.6540226378555745;[HSD3B7, CXCL9, CXCL11, CCL3L1, CCL20, CCL5, CCL3, CCL2, CCL19, PIK3CG, CCR2]
GO:0048246;macrophage chemotaxis;8.0;1.0;0.875;9.628524252492122;95.91852822164125;7.212124270218933;0.0032103068185073717;0.7438283705770736;[CCL5, CCL3, CCL2]
GO:0045893;positive regulation of transcription, DNA-templated;10.0;0.5159906454948852;0.673236334608363;8.141425192250265;1208.1179641469014;2.4745772039531437;0.04043462102441837;0.5417910051506925;[ZNF175, CCNK, MAML1, CCNH, GFI1, ZNF292, IKZF1, GPATCH3, IKZF2, ELK1, RPS6KA4, RPS6KA5, MYC, ZXDC, DPF2, TRIM24, SOX8, SOX6, IER5, ATXN7L3, IER2, CDK5RAP3, DDX17, MEF2B, FLT3LG, MED6, RUNX2, RUNX1, SFRP1, SFRP2, KARS, IL23A, RFX4, HOXB4, ATF4, PAXIP1, NOLC1, ZNF24, HSPH1, RAD21, HLTF, SCAP, HOXC4, ZBED1, PPARGC1B, ZNF143, CREBBP, XBP1, XRCC6, JUP, PBX3, EIF2AK3, EAF2, ERLIN2, FLI1, SETX, STAG1, CDKN1C, ARF4, CD40, SETD3, ELL, HOXC13, BRCA1, AATF, WDR43, HOXC10, MED12, NIPBL, ING2, HYAL2, MLX, SPIN1, HRAS, TEAD2, ZNF485, SEC13, NCOA6, SIRT7, TMEM173, PPRC1, SIRT2, GNL3, GAL, MTF2, TFEC, RARA, MAPRE3, ZNF350, HEATR1, GPS2, RELA, ARNTL, SERTAD3, BCLAF1, RXRA, SERTAD2, PLAGL2, GPBP1L1, ZNF462, CD74, NFYC, ATAD2, GRHL1, NFIA, NFIB, TTC5, NFIC, CAMK4, MARS, PSMC1, CAMK1, MIXL1, CRTC2, NCF1, CD80, ARID4A, RORA, YEATS4, UBE3A, PARK7, YY1, STK16, EP300, HMGN3, ZNF564, MAP3K5, FBXW11, PIAS2, ARMCX3, ILF3, TBL1XR1, CCNE1, MAX, RLF, SUPT6H, BCL2L12, MED30, DVL3, NLRP3, RIPK1, CYTL1, BPTF, TFAP2A, ZBTB17, DR1, NFKB1, CDK9, NFKBIA, NR4A2, BCL9, CDK8, IL6, TFCP2, COPS5, CNOT7, SP1, SP3, MAFF, BCL3, CDK2, NFE2L3, MNAT1, NFE2L1, PHF19, PICALM, CIITA, BMPR2, ONECUT2, THRA, CHD8, CHD7, DDX41, LDB2, PKD2, CKS1B, FLCN, LBH, SIN3A, NUP62, ARHGEF11, MKL2, KLF10, TBP, KLF13, RBM15, PPP1R12A, PEG3, DTX3L, RFC1, MKL1, ARNT, SENP2, SAFB, ARID1A, ZFP90, TGFBR1, DNM2, CREB3, TFDP1, RBL1, TFDP2, ELF4, IRF4, THRAP3, ZNF516, EAPP, MET, HDAC3, HDAC1, WBP2, CEBPE, CEBPG, TP53INP2, TP53INP1, PCBD1, MTA2, E2F7, E2F8, TBX1, RNF20, TCF7L2, CHURC1, TAF15, CDC5L, ARID3B, USF2, POMC, CD4, KLF6, TNIP1, TNIP2, ASXL2, TAF7, TAF4, SSBP3]
GO:0048245;eosinophil chemotaxis;9.0;1.0;0.896240625180289;9.628524252492122;130.2972973825895;6.7325511899570465;0.004360933283440787;0.740543606130341;[CCL5, CCL3, CCL2]
GO:2000353;positive regulation of endothelial cell apoptotic process;9.0;1.0;0.896240625180289;9.628524252492122;129.82178199018807;6.943860283624253;0.00434501821119318;0.7513499630073597;[CD40, CCL2, THBS1]
GO:0050435;amyloid-beta metabolic process;6.0;0.9326813400603323;0.7894609826203107;9.533214072687796;60.01596331221528;6.943860283624253;0.0020086802811995464;0.6782296504172152;[BECN1, MME, PSEN2]
GO:0051402;neuron apoptotic process;5.0;0.8259837884571596;0.7032329060895001;9.022388448921806;23.44398779513952;6.113511981550823;7.846491732841165E-4;0.6028862989048107;[POLB, PIGT, CDK5, DIABLO, MAX, CASP3, BAX, BID, GAPDH, CIT]
GO:0070723;response to cholesterol;6.0;0.9326813400603323;0.7894609826203107;9.523163736834295;80.91680144162417;6.686031174322154;0.002708212523857764;0.665044257777226;[CCL3, LRP8, AACS, TGFBR1]
GO:1903896;positive regulation of IRE1-mediated unfolded protein response;9.0;1.0;0.896240625180289;9.628524252492122;384.04585750344626;7.8311634786251565;0.012853669231808067;0.7967266896635242;[BAX]
GO:1902445;regulation of mitochondrial membrane permeability involved in programmed necrotic cell death;7.0;1.0;0.8509193652572005;9.628524252492122;52.52727335290614;8.67846133901236;0.001758040567644875;0.7947362817240173;[PPIF, BAX, ALKBH7]
GO:0006611;protein export from nucleus;9.0;0.7508913569872202;0.7716863036738992;9.277126365654233;128.4390295807893;5.948432231191374;0.00429873873244698;0.7004437261138039;[RPS15, AHCYL1, RANBP3, NUP62, XPO5, BCCIP]
GO:0045657;positive regulation of monocyte differentiation;9.0;1.0;0.896240625180289;9.628524252492122;840.3783565179247;7.57984905034425;0.02812670730123667;0.7838744581139225;[CD74, CD4, ACIN1]
GO:0051770;positive regulation of nitric-oxide synthase biosynthetic process;7.0;1.0;0.8509193652572005;9.628524252492122;147.28763043943843;7.069023426578259;0.0049295844405465;0.7124295520356204;[CCL20, FNTB, CCL2]
GO:0006729;tetrahydrobiopterin biosynthetic process;8.0;1.0;0.875;9.628524252492122;752.8847007962319;7.8311634786251565;0.02519837338340958;0.7754860644832351;[PCBD1]
GO:0006606;protein import into nucleus;9.0;0.8933024483968273;0.8428918493787028;9.551563211355994;277.5355368998559;5.288437257948329;0.009288864654271135;0.6666915524892495;[MBTPS1, NUP107, RANBP3, SYK, NUP153, PRICKLE1, RGPD1, IPO7, IPO4, NUP93, NCKIPSD, IPO8, IPO9, NUP62, LMNA, HEATR3, KPNA4, TNPO1, TNPO2, RAE1, KPNB1, TNPO3]
GO:0043484;regulation of RNA splicing;7.0;0.7671156992804218;0.7344772148974115;9.34084218004034;89.9604162809808;4.901876304479318;0.0030108941738060855;0.601601547428833;[DDX17, MBNL1, WTAP, AHNAK, YTHDC1, CLK4, CLK3, SETX, CLK1, ERN1, RBM3, PTBP1, SON, U2AF2, THRAP3, C1QBP, SAP18, ZNF326, RBM5]
GO:0072332;intrinsic apoptotic signaling pathway by p53 class mediator;7.0;0.8933024483968273;0.7975705894556142;9.446202695698167;80.0523555558605;5.734022359845919;0.002679280298012042;0.64415753539903;[CDKN1A, ZMAT1, PERP, BCL3, DDIT4, TP53BP2, EP300, BAX, KRCC1]
GO:0048255;mRNA stabilization;10.0;0.8933024483968273;0.861892236059334;9.577230958104572;1968.7172834448895;6.088194173566533;0.06589119574637584;0.7265915450270957;[THRAP3]
GO:0001836;release of cytochrome c from mitochondria;6.0;1.0;0.8231203125901445;9.628524252492122;22.134985108306864;6.686031174322154;7.408380313817617E-4;0.665044257777226;[BAX, BID, BBC3]
GO:0051897;positive regulation of protein kinase B signaling;8.0;1.0;0.875;9.628524252492122;238.41769229280743;4.7664383335842135;0.007979625599047746;0.6187558780415471;[PDGFRB, ITGB1, TCF7L2, IGFBP5, ANGPT1, CD80, PARK7, THBS1, VAV1, PIK3CG, TGFBR1, STK3, MTDH, BAG4, C1QBP, KIT, CPNE1, CCL3, CCL19, TEK, MET, HBEGF]
GO:0043922;negative regulation by host of viral transcription;11.0;1.0;0.9324289523296623;9.628524252492122;272.3838172918008;7.292166977892469;0.009116441235236167;0.8053507106995271;[HDAC1, CCL5, CCL3]
GO:0000956;nuclear-transcribed mRNA catabolic process;9.0;0.6873818243518346;0.7399315373562063;9.295818498666385;714.7700062418027;4.519578255652688;0.023922708857670925;0.6273720673562503;[HBS1L, SMG1, RPL3, EIF4A3, PPP2R2A, CASC3, SMG5, PPP2CA, RPS15, DHX34, POLR2G, EXOSC3, DCPS, RPL19, UPF2, UPF1, RPS9, RPS7, DIS3, PAPD4, CNOT10, RPL23A, UPF3A, RPSA, LSM5, PNRC1, PNRC2, CNOT4, CNOT6, PAN3, CNOT7, XRN1, CNOT1, THRAP3, CSDE1, CNOT3, MRTO4, SKIV2L, ETF1, CNOT8, DCP1A, RPL29, DCP2]
GO:0043123;positive regulation of I-kappaB kinase/NF-kappaB signaling;8.0;0.8933024483968273;0.8216512241984136;9.517298617381897;239.11083947336738;4.629579150867016;0.008002824611389124;0.6117568930727868;[ANKRD17, CD40, SLC20A1, TRADD, SECTM1, CXXC5, RELA, MTDH, AKAP13, CASP8, TFG, CASP10, UBD, NUP62, ABL1, RIPK1, CCL19, ECT2, TMED4, MAP3K3, CD74, UBE2I, PRKCE, ZDHHC13, TNFRSF10B, IRAK4, RHOC, ZDHHC17, CD4, VAPA, TNIP2, LTBR, TRIM32, CARD11, BIRC3]
GO:0097192;extrinsic apoptotic signaling pathway in absence of ligand;7.0;1.0;0.8509193652572005;9.628524252492122;76.30875120206336;6.375876246018314;0.0025539852293156346;0.6769819729871445;[BAG3, EYA2, CASP3, MKNK2, CASP2, BAX, ITGAV, APPL1]
GO:0044458;motile cilium assembly;7.0;1.0;0.8509193652572005;9.628524252492122;138.7811185870196;6.641579411751319;0.004644879144209681;0.6905700452391912;[CENPJ, MKS1]
GO:0000398;mRNA splicing, via spliceosome;11.0;0.8259837884571596;0.845420846558242;9.4949928598676;356.66873027722005;4.19357731889877;0.011937381421361158;0.6468886914394342;[EIF4A3, DDX42, DDX41, CASC3, USP39, EFTUD2, UBL5, PTBP1, RAVER1, PCF11, DHX16, RBM5, DDX17, AQR, RBM15, BUD31, TFIP11, SRRM1, PRPF4, PSPC1, PRPF3, SNRPG, CD2BP2, SLU7, SF1, SF3B5, SF3B2, WBP4, DDX23, PRCC, RNF113A, PABPN1, U2AF2, POLR2B, POLR2E, SNRPB2, POLR2G, POLR2I, SMNDC1, DCPS, SF3B1, POLR2K, SPEN, PRPF38A, GPKOW, CPSF3, NONO, CPSF2, CDC5L, CWC15, LSM5]
GO:0000165;MAPK cascade;9.0;0.7436939687323844;0.7680876095464813;9.236482164716097;231.45054935470895;4.069963362931594;0.007746441594931149;0.6043787408332628;[OXTR, YWHAB, IL5RA, RASGEF1A, MYC, CTSH, ITGAV, HRAS, MAP3K5, PDGFRB, DUSP5, MAP4K2, KSR1, FBXW11, PAQR3, IRAK4, GFRA2, SPTB, ITPKB, KARS, KIT, MET, HBEGF, PTGER4, CAMK2D, GPS1, GPS2, IL2RG, RASGRP4, RASGRP3, PABPN1, CCL5, CCL3, CCL2, NCAM1, MBP, RIPK1, SULT1A3, MAP3K3, MAP3K1, ANGPT1, NFKB1, MAPK13, SETX, PTPRA, TNIP2, TAOK2, CCM2, KRAS, TEK, CALM1]
GO:0043491;protein kinase B signaling;6.0;1.0;0.8231203125901445;9.628524252492122;26.42836680105094;6.250713103064308;8.845336528452411E-4;0.6427820713687392;[SETX, CD40, CCL5, PTEN, CCL3, CCL2, SIRT2]
GO:0045672;positive regulation of osteoclast differentiation;9.0;0.9326813400603323;0.8625812952104552;9.587702257971866;840.7838216260375;6.599019797332524;0.0281402778535103;0.7337148045016781;[KLF10, IL23A, PPARGC1B]
GO:0071277;cellular response to calcium ion;6.0;1.0;0.8231203125901445;9.628524252492122;78.50383844342444;5.433268205826786;0.0026274528238337297;0.6009779013089371;[CAMK2D, ENDOG, CACYBP, ARID1A, RASGRP2, TUBG1, PKD2, ITPKB, PPIF, CPNE1, CPNE3, CPNE2, ECT2]
GO:0048026;positive regulation of mRNA splicing, via spliceosome;10.0;0.9326813400603323;0.8815816818910864;9.593432932680852;1178.6990535440698;6.686031174322154;0.03944999656184221;0.7571649570480019;[RBM3, THRAP3]
GO:0048147;negative regulation of fibroblast proliferation;6.0;0.8933024483968273;0.7697715367885581;9.427853557029971;63.87354995152188;6.409777797693995;0.0021377902344145586;0.6509166472493662;[SFRP1, MYC, TP53INP1, BAX, TRIM32, B4GALT7, EMD]
GO:0048146;positive regulation of fibroblast proliferation;6.0;0.8933024483968273;0.7697715367885581;9.427853557029971;63.74573076450893;5.825829909099042;0.0021335122412550348;0.6210535250702663;[PDGFRB, CD74, CDKN1A, CCNB1, CDK6, SPHK1, MYC, FNTB, AQP1]
GO:0060828;regulation of canonical Wnt signaling pathway;7.0;0.6954798709641801;0.6986593007392905;8.83001655627435;44.04846258837617;4.37439624580819;0.0014742624017903352;0.5746261926980603;[HDAC1, CHD8, USP34, KLHL12, PRICKLE1, STK4, ARNTL, STK3, UBR5, DVL3, EMD, DACT1, TLE4, USP8, TCF7L2, JUP, CAV1, FZD6, NFKB1, AES, PPP1CA, CYLD, SFRP1, SFRP2, TBL1XR1, GNAQ, RAPGEF1, MKS1]
GO:0006816;calcium ion transport;8.0;0.6696747006330769;0.7098373503165385;8.690254613899192;35.67391733828006;4.3132418226548594;0.001193973908871026;0.5955793873968269;[STOML2, PSEN2, ITPR2, ATP2A2, PKD2L1, PKD2, CORO1A, CCL5, CDH23, CCL3, PMPCB, ITGAV, CCL19, TRPM6, ATP13A1, CAV1, PRKCE, CACNA2D3, ATP2B4, TRPC4AP, BSPRY, P2RX7, P2RX4, GRIN3A, CDK5, NMUR1, ATP13A3]
GO:0045671;negative regulation of osteoclast differentiation;9.0;0.9326813400603323;0.8625812952104552;9.587702257971866;842.5336305879634;6.481236761676141;0.028198842384740134;0.7276913745807394;[SFRP1, GPR55, CCL3, LILRB3]
GO:2000134;negative regulation of G1/S transition of mitotic cell cycle;9.0;0.7980440201809971;0.7952626352707877;9.394909401310617;355.88113835876356;5.244474134527214;0.011911021428637128;0.6644432763129993;[BTG2, CDKN1A, PCNA, PTEN, PKD2, CCNB1, CASP2, EP300, CCL2, GTSE1, E2F7, E2F8, DACT1, CNOT10, CNOT4, CNOT6, TFDP1, RBL1, CNOT7, TFDP2, CNOT1, CTDSP2, RFWD3, CNOT3, CDK2, BAX, ZNF655, CNOT8, EZH2]
GO:0061101;neuroendocrine cell differentiation;7.0;0.811012628672052;0.7564256795932265;9.0689084645567;26.97430872096675;7.8311634786251565;9.028058375889943E-4;0.7514054297404357;[BCCIP]
GO:0070979;protein K11-linked ubiquitination;11.0;1.0;0.9324289523296623;9.628524252492122;157.60047254366168;6.375876246018314;0.00527474598481953;0.7584915600596062;[ANAPC13, FZR1, UBE2B, UBE2T, CDC26, UBE2E3, CDC16, UBE2D3, ANAPC5, ANAPC11, UBE2L3]
GO:2001241;positive regulation of extrinsic apoptotic signaling pathway in absence of ligand;10.0;1.0;0.9152410118609203;9.628524252492122;424.359905324836;7.292166977892469;0.01420294413210246;0.7881627702307852;[BAX, PPP1CA]
GO:1900044;regulation of protein K63-linked ubiquitination;11.0;0.8259837884571596;0.845420846558242;9.503361109538115;81.58725843565168;7.474488534686424;0.002730652116075744;0.8146746435927894;[UBR5, GPS2, PTPN22, SASH1]
GO:0090200;positive regulation of release of cytochrome c from mitochondria;9.0;1.0;0.896240625180289;9.628524252492122;472.23248408711356;6.409777797693995;0.015805196260752157;0.7240369598395108;[HRK, PLAUR, PPIF, BAX, BID, BBC3]
GO:0044344;cellular response to fibroblast growth factor stimulus;6.0;1.0;0.8231203125901445;9.628524252492122;97.48528473772916;6.444869117505266;0.003262744749111514;0.6527112189764278;[SETX, TBX1, SFRP1, CCL5, HYAL2, CDC5L, CCL2]
GO:0005981;regulation of glycogen catabolic process;9.0;0.8933024483968273;0.8428918493787028;9.52844079393514;259.5639280205376;7.9853141584524145;0.008687371078478277;0.8046099625986299;[PPP1CA]
GO:0006397;mRNA processing;8.0;0.7140352122741334;0.7320176061370667;9.165900730544008;234.3529203123214;3.6745150330669007;0.00784358133891816;0.5629148696734654;[AHCYL1, CCNH, EIF4A3, DDX42, DDX41, CASC3, USP39, EFTUD2, UBL5, PTBP1, ALKBH5, RAVER1, PCF11, C1QBP, ARL6IP4, DHX16, ZNF326, RBM5, DDX17, AQR, MBNL1, RBM15, BUD31, SSU72, PAPD4, TFIP11, THOC2, SRRM1, THOC6, ERN1, PRPF4, PSPC1, THRAP3, PRPF3, XRN2, FASTKD5, SNRPG, CD2BP2, SLU7, SF1, TRUB2, SF3B5, SF3B2, POLDIP3, WBP4, DDX23, PRCC, SUPT6H, RNF113A, PABPN1, U2AF2, POLR2B, POLR2E, SAP18, SNRPB2, POLR2G, POLR2I, SMNDC1, DCPS, SF3B1, POLR2K, SPEN, CPSF6, PRPF38A, PNPT1, PTCD2, GPKOW, WTAP, CPSF3, NONO, CPSF2, CDC5L, CWC15, LSM5, GTF2H4, PAN3, SON, ACIN1, MNAT1, GRSF1]
GO:1904886;beta-catenin destruction complex disassembly;5.0;1.0;0.7902410118609202;9.628524252492122;38.04764185170599;6.7325511899570465;0.0012734203321220245;0.6345439928109722;[CAV1, DVL3, PPP1CA]
GO:0009306;protein secretion;8.0;0.5696777571895439;0.659838878594772;7.923776160253697;130.2874189859313;4.786641040901733;0.004360602662394617;0.6197890454332871;[RAB3B, STEAP3, SUCNR1, ANXA1, RAB3D, FGG, MIA3, NLRC4, BTN3A2, PARK7, GAL, SNX19, GPAM, NLRP3, LCP2, ITGAV, COPG2, CCL19, TRIM27, CARD11, PAFAH1B1, RAB8B]
GO:0000055;ribosomal large subunit export from nucleus;13.0;1.0;0.9625549647676366;9.628524252492122;269.30067979732365;7.292166977892469;0.009013251397939615;0.8354767231375014;[BCCIP]
GO:0005977;glycogen metabolic process;7.0;0.8653626801206646;0.7836007053175329;9.523163736834295;182.57737249811964;5.885253329569843;0.006110700348544658;0.6518914942236709;[PPP1CB, PER2, PPP1CC, PYGB, UGP2, PGM5, PPP1CA]
GO:0005979;regulation of glycogen biosynthetic process;9.0;0.8933024483968273;0.8428918493787028;9.541512875502493;342.46968566496105;6.481236761676141;0.011462152176499362;0.7276913745807394;[PPP1CA]
GO:0048278;vesicle docking;5.0;0.811012628672052;0.6957473261969462;9.176539128749065;21.38880323109876;5.618190544320798;7.158639954716971E-4;0.5775555375700647;[RAB3B, VPS18, VPS33A, RAB3D, VPS33B, VPS11, EXOC4, STX5, VPS45, RABEPK, STX11, RAB8B]
GO:0016064;immunoglobulin mediated immune response;6.0;0.7586651285174919;0.7024528768488905;9.040737587590003;30.584352397600135;7.069023426578259;0.0010236307506175364;0.6846304993685643;[CD74, IL4R, FCER1G, EXO1, BCL3, PRKCD, HLA-DQB1]
GO:0030593;neutrophil chemotaxis;9.0;1.0;0.896240625180289;9.628524252492122;130.2972973825895;5.382624473008031;0.004360933283440787;0.671508291047556;[CXCL6, CXCL9, FCER1G, SYK, CCL3L1, CCL20, ITGB2, VAV1, PIK3CG, PREX1, CXCL11, CCL5, CCL3, CCL2, NCKAP1L, CCL19]
GO:0002904;positive regulation of B cell apoptotic process;10.0;0.8436909121759173;0.837086467948879;9.466005322994347;154.91562423562246;8.67846133901236;0.00518488652815606;0.8590579283277371;[BAX]
GO:0050900;leukocyte migration;5.0;0.6023560406934092;0.5914190322076249;8.01908634005802;26.939797568556347;3.896540641279769;9.016507803758389E-4;0.4895102814636384;[ITGB1, CXCL6, CXCL9, WDR1, DOCK8, ITGB3, ITGB2, SIRPG, LYST, PIK3CG, PREX1, ITGAV, CCR2, FCER1G, ANXA1, SYK, ATP1B2, IRAK4, VAV1, DOK2, KIT, MYH9, ARHGEF5, GYPA, CCL3L1, CD99L2, CORO1A, GLG1, CCL5, CCL3, CCL2, NCKAP1L, CCL19, HSD3B7, CD74, ANGPT1, CCL20, CAV1, TNFRSF10B, MSN, TNFRSF10A, NLRP12, IL6, CXCL11, COL1A2, SDC1, PTPN6, TEK, CD244]
GO:0002906;negative regulation of mature B cell apoptotic process;11.0;1.0;0.9324289523296623;9.628524252492122;225.7390073925085;8.390779266560578;0.007555281425510346;0.8615337942327104;[CD74]
GO:0070059;intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress;7.0;0.9326813400603323;0.8172600352873667;9.55953138100517;84.12593595584649;6.343086423195323;0.002815619368015229;0.6753050999230941;[ERN1, PPP1R15A, XBP1, TNFRSF10B, BAX, TRIB3, BBC3, MAP3K5, ATF4]
GO:2001234;negative regulation of apoptotic signaling pathway;8.0;0.6913464685778243;0.7206732342889122;9.146686165599384;292.02860154420875;4.420487353008457;0.00977393448500626;0.601063928806537;[TRADD, BRCA1, PARK7, THBS1, RELA, BCL2L12, ING2, HSPH1, CASP8, LMNA, RIPK1, ITGAV, RFFL, BID, CDKN2D, FGA, TCF7L2, CD74, PRELID1, XBP1, EYA2, WFS1, NONO, FGG, SYVN1, PLAUR, TNFRSF10B, TNFRSF10A, TGFBR1, NR4A2, CREB3, SFRP2, QARS, TMBIM1, PPIF, VDAC2, BAX, HYOU1, BIRC6, TRIM32]
GO:0007051;spindle organization;6.0;0.6873818243518346;0.6668112247660618;8.690254613899192;44.522636097919765;4.786641040901733;0.0014901325624263064;0.5679093580234316;[HDAC3, DCTN2, TUBGCP2, BCCIP, CCNB1, SPAST, KIF3B, NUF2, ZNF207, FBXO5, CLASP1, RANBP3, TUBG1, CKAP5, NDC80, RAB11A, CENPE, NCOR1, ESPL1, KIF4A, TBCE, MYH9, MAPRE3, MAPRE1, KPNB1, SPC25, BIRC3]
GO:0008380;RNA splicing;8.0;0.7248374789738407;0.7374187394869203;9.182237149863703;117.47952805794706;3.8501476017100584;0.003931934079388465;0.5718967274016261;[EIF4A3, DDX42, DDX41, CASC3, USP39, EFTUD2, UBL5, PTBP1, RAVER1, PCF11, C1QBP, ARL6IP4, DHX16, ZNF326, RBM5, DDX17, AQR, MBNL1, RBM15, BUD31, TFIP11, THOC2, SRRM1, THOC6, ERN1, PRPF4, PSPC1, THRAP3, PRPF3, ZNF638, SNRPG, CD2BP2, SLU7, SF1, SF3B5, SF3B2, WBP4, DDX23, PRCC, SUPT6H, PPP2CA, RNF113A, PABPN1, U2AF2, POLR2B, POLR2E, SAP18, SNRPB2, POLR2G, POLR2I, SMNDC1, DCPS, SF3B1, POLR2K, SPEN, PRPF38A, GPKOW, WTAP, CPSF3, NONO, CPSF2, CDC5L, CWC15, LSM5, SON, ACIN1]
GO:0043308;eosinophil degranulation;9.0;1.0;0.896240625180289;9.628524252492122;132.80263134205524;8.67846133901236;0.004444784556409926;0.8400575416471059;[CCL3]
GO:0036297;interstrand cross-link repair;8.0;0.8933024483968273;0.8216512241984136;9.541512875502493;183.0506323445446;5.905872616772578;0.006126539929698291;0.6770266002729131;[RAD51AP1, FANCI, DCLRE1A, DCLRE1C, RAD51, FANCL, UBE2T, RFWD3, FANCE]
GO:0007179;transforming growth factor beta receptor signaling pathway;8.0;0.7586651285174919;0.754332564258746;9.05316010758856;29.903672154863813;5.2552850506314295;0.0010008489954655988;0.6437555218850388;[DUSP22, KLF10, TWSG1, FUT8, COL1A2, BMPR2, PTPRK, TGFBR1]
GO:1902512;positive regulation of apoptotic DNA fragmentation;9.0;1.0;0.896240625180289;9.628524252492122;902.4454322749122;8.67846133901236;0.030204036470081387;0.8400575416471059;[ENDOG, BAX]
GO:0051291;protein heterooligomerization;6.0;0.8933024483968273;0.7697715367885581;9.405380701177911;42.032160359171186;5.113634533568402;0.00140677858073304;0.5846318204451575;[HBZ, CD74, RRM1, SEPT11, XRCC6, CPSF6, JUP, RIPK3, YWHAB, TRADD, HBE1, IKZF1, HSD17B8, PRKAB1, GCHFR, BAG4, COL1A2, NUP62, RIPK1, PCBD1, FARSA, HRAS, S100A10, BIRC3]
GO:0006886;intracellular protein transport;8.0;0.5537205960740763;0.6518602980370382;8.117066748418225;90.55259897265384;3.0436717358431102;0.0030307139955665606;0.5306535141162272;[RAB3B, VPS29, AHCYL1, RPL3, NUP107, NCF1, PDCD6, RAB3D, UBE2D3, BCCIP, ZDHHC6, TBC1D3C, IPO7, IPO4, PEX26, RAB43, RPH3A, RPS15, IPO8, IPO9, LAMP2, LONP2, ARFIP1, HOMER3, KPNA4, TBC1D22A, SIL1, VPS18, GSTK1, RPS9, RPS7, COG3, AP1B1, TOMM34, TBC1D2B, RPSA, MYO7A, SYTL3, BCR, NUP93, RAB35, ACOT2, CHMP4B, RAB38, RPL29, SLC27A2, KPNB1, ACOT4, RTN2, COPB2, COPA, RAB5C, VPS26A, VPS26B, HSP90B1, NCKIPSD, CLTCL1, VPS11, SSR1, RAB6A, TBC1D17, TBC1D15, VPS16, AP1M1, CTSA, RAB4B, PMM1, RAB3IP, PMM2, ASPSCR1, NUP153, RAB27B, TIMM44, NFKBIA, POLA2, PAN3, NPLOC4, CDK5, BCL3, HYOU1, CD24, ARF3, ARF4, TRAM1, YWHAB, SRP54, CLTA, SEC61A2, AP1G2, AP1G1, NUP62, XPO5, KIF13B, TMED2, TLK1, TMED1, AP3S2, EVI5L, TNPO1, TMED7, TNPO2, ARL5A, TNPO3, RAB8B, TMED4, GRIPAP1, TMED9, SEC13, SYK, SSR2, SSR3, TBC1D8, ZDHHC12, RHOB, TBC1D3, ACOX2, AGPS, CAT, EXOC4, SLU7, ARF5, RABGAP1, TOMM40, RAB1B, ZDHHC23, HSD17B4, ZDHHC24, DERL2, PRICKLE1, TRAK1, RGPD1, NAPG, STX11, ARNTL, RAB21, AP3M1, RAB20, GGA3, RAB40C, LMNA, AP2S1, HEATR3, STX5, MFN2, RAB28, BID, RAE1, RPL19, PEX16, TIMM8B, MBTPS1, CD74, PEX19, RANBP3, AGK, SYVN1, RPL23A, GDAP1, RAB11A, ARCN1, DHRS4, SPCS2, SNX17, VPS41, RAB13, TAOK2, RAB18, RUNDC1, RAB3GAP2, COPG2, VPS45, SEC24C]
GO:0051290;protein heterotetramerization;7.0;1.0;0.8509193652572005;9.628524252492122;85.45061507946225;6.444869117505266;0.002859955186148837;0.6805102716434839;[CD74, RRM1, XRCC6, CPSF6, FARSA, HSD17B8, S100A10]
GO:0043547;positive regulation of GTPase activity;6.0;0.9326813400603323;0.7894609826203107;9.523163736834295;49.33745512692421;3.758480413184235;0.001651280222271285;0.5153291757075998;[ITGB1, ERRFI1, CD40, DOCK8, DENND1A, ARHGAP1, TBC1D3C, DOCK11, PREX1, RGS1, ARHGDIB, EVI5L, TBC1D22A, HRAS, ARHGEF11, SEC13, TBC1D8, TBC1D2B, GMIP, VAV1, ARFGAP1, BCR, TIAM2, DEPDC1B, SFRP1, TBC1D3, ALS2, TBC1D20, CDC42EP4, DEPDC1, RAPGEF1, PKP4, TAX1BP3, ARHGEF1, RIN3, DOCK2, EPHA1, ARHGEF5, RABGAP1, RGS19, CCL3L1, RASGRP2, RASGRP3, RIC8A, ABR, ARHGAP21, RIC8B, CCL5, CCL3, DVL3, CCL2, NCKAP1L, CCL19, ECT2, A2M, TBC1D17, TBC1D15, S100A10, STARD13, RANBP3, SEMA4D, CCL20, RCC2, MYO9B, ARHGAP26, ARHGAP25, ARHGAP30, GNAQ, RUNDC1, RAB3GAP2, SMAP1, RAB3GAP1, EZH2, LIMS1, PICALM]
GO:0097296;activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway;14.0;1.0;0.9759193652572005;9.628524252492122;1176.1232083486027;8.390779266560578;0.0393637853412601;0.9050242071602486;[CASP8, BAX]
GO:0051169;nuclear transport;5.0;0.6302958089695718;0.6053889163457062;8.048073876931273;33.20429938101479;4.224114042758852;0.0011113180183532213;0.5062624004489997;[SMG1, AHCYL1, NUP107, EIF4A3, BCCIP, CASC3, IPO7, SMG5, IPO4, RPS15, AKAP13, ALKBH5, IPO8, IPO9, NUP62, XPO5, KPNA4, BANF1, TNPO1, TNPO2, TNPO3, UPF2, UPF1, SYK, RPSA, THOC2, SRRM1, THOC6, NUP93, LSG1, SNRPG, SLU7, KPNB1, FYTTD1, SEH1L, POLDIP3, PRICKLE1, RGPD1, NOL6, NCKIPSD, NXF3, PABPN1, U2AF2, TPR, LMNA, HEATR3, NUP43, RAE1, MBTPS1, RANBP3, CPSF3, CPSF2, NUP153, UPF3A, CDK5, RAB18, CAMK1]
GO:0030502;negative regulation of bone mineralization;7.0;0.9326813400603323;0.8172600352873667;9.55953138100517;172.15796001199809;6.943860283624253;0.005761971989496609;0.7060287030842711;[CCL3]
GO:0002830;positive regulation of type 2 immune response;6.0;0.8933024483968273;0.7697715367885581;9.461470167828956;108.5833891387084;7.069023426578259;0.0036341883157667808;0.6846304993685643;[CD74, IL6, IL4R, RARA, NLRP3]
GO:0050870;positive regulation of T cell activation;8.0;0.6260725219892441;0.688036260994622;8.781226392104918;216.0655637178415;4.493869898942481;0.007231519971253338;0.6048167156182404;[CD83, TFRC, DOCK8, CD80, SIRPG, EBI3, CORO1A, AGER, HLA-DMB, HSPH1, CCL5, NFKBIZ, NLRP3, CTLA4, CCL2, NCKAP1L, CSK, IL12A, CCL19, IL12RB1, CCR2, HLA-DPA1, HAVCR2, CD74, XBP1, IL4R, ANXA1, SYK, TNFSF14, CAV1, PDCD1LG2, VAV1, RUNX1, ITPKB, CCDC88B, CYLD, CD4, IL6, GPAM, IL23A, HLA-DPB1, RARA, PTPN6, PDCD1, CD24, IL7R, CARD11]
GO:0032922;circadian regulation of gene expression;6.0;1.0;0.8231203125901445;9.628524252492122;31.18462308171688;5.769740442447999;0.0010437212702063816;0.618185107137305;[PPP1CB, PER2, PPP1CC, HDAC1, RORA, ARNTL, ATF4, PPP1CA]
GO:0051289;protein homotetramerization;7.0;1.0;0.8509193652572005;9.628524252492122;85.45061507946225;5.433268205826786;0.002859955186148837;0.6287769539759931;[VASP, CRTC2, GPX3, DCXR, ATPIF1, PKD2, SAMHD1, ACACA, GLS, RXRA, ALDH5A1, IMPDH2, PPAT, CAT, PCBD1, ALDOA, ACPP]
GO:0050758;regulation of thymidylate synthase biosynthetic process;6.0;0.8933024483968273;0.7697715367885581;9.446202695698167;73.9842258934068;9.083926447120524;0.0024761854591718573;0.7876727335416686;[FOLR2]
GO:0019722;calcium-mediated signaling;7.0;0.7192862368539868;0.710562483684194;8.712233520617966;27.814661162170232;4.835431205071165;9.309316775279788E-4;0.598203541955087;[PRNP, CAMK2D, MCTP1, CCL20, SPHK1, EIF2AK3, ATP2A2, DEFB1, CALML4, P2RX4, RCAN3, CCL3, NMUR1, CALM3, CALM1, CALM2, CCR10, SULT1A3, CCR2]
GO:2001244;positive regulation of intrinsic apoptotic signaling pathway;9.0;0.7671156992804218;0.7797984748205;9.413412872875176;596.4251749563025;5.75172193694532;0.019961813857978603;0.6903839525180965;[BCLAF1, FBXO18, RPS7, RIPK3, CAV1, PLAGL2, BAX, PARK7, SERINC3, BID, SOD1, ATF4]
GO:0016558;protein import into peroxisome matrix;11.0;1.0;0.9324289523296623;9.628524252492122;631.8486156540207;7.474488534686424;0.021147404539104363;0.8146746435927894;[PEX16, PEX26]
GO:0007186;G-protein coupled receptor signaling pathway;5.0;0.5508212674310002;0.5656516455764204;7.20077601654407;23.17027026302992;2.605416804911955;7.75488093814194E-4;0.4234821484283897;[CXCL6, OXTR, CXCL9, AHCYL1, DGKD, DGKA, DEFB1, PIK3CG, HEBP1, AKAP13, PREX1, GPR132, GNAT2, RGS1, ADORA3, NPPA, OR56B1, HOMER3, PDE8A, CCR2, PDGFRB, ARHGEF11, CD97, ANXA1, SPHK2, SPHK1, AGTRAP, RHOC, ADRA2C, VAV1, VAV2, RHOB, TIAM2, SFRP1, GAL, SFRP2, ADORA2A, SPNS1, ARHGEF1, DAGLB, GPRC5D, ARHGEF5, XPR1, ATF4, PTGER4, SUCNR1, RGS19, CCL3L1, ROCK2, ADCY4, IQGAP2, CRHR1, RIC8A, C3, P2RY8, ABR, GNG2, RIC8B, TBXA2R, HRH2, CCL5, GRK6, CCL3, GNG8, CCL2, CCL19, ECT2, NTSR1, CCR10, SULT1A3, SLC12A2, CCL20, CAV1, GPR55, FZD6, TSHR, BAIAP3, POMC, CXCL11, GPR180, GNAQ, GNB2, PNOC, NMUR1, CALM3, PTPN6, CALM1, CALM2]
GO:0007187;G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger;6.0;0.6997970393407541;0.6730188322605215;8.578702127993445;26.976932752798508;4.347727998726029;9.028936615729279E-4;0.5454633246350222;[PTGER4, ANXA1, ADCY4, ADRA2C, CRHR1, TSHR, RIC8A, AKAP13, GNG2, GNAT2, ADORA2A, RGS1, TBXA2R, HRH2, GNAQ, CCL2]
GO:1901796;regulation of signal transduction by p53 class mediator;7.0;0.7192862368539868;0.710562483684194;9.117698628726131;45.070113835906206;4.948759890378168;0.001508456149618737;0.6039991761920099;[CD74, TBP, TAF15, CSNK2A1, RPS7, SENP2, BCL2L12, BOP1, NUAK1, ING2, TTC5, TP53INP1, CDK2, TRIM24, TP53BP2, EP300, TAF7, TAF5, RFFL, TAF4, CDK5RAP3]
GO:0045732;positive regulation of protein catabolic process;7.0;0.7043150770688792;0.7030769037916401;9.033817144745429;231.0521549826792;4.39257856489138;0.0077331076938309705;0.5755560373415389;[USP13, ZFAND2A, PTEN, PRICKLE1, FZR1, GGA3, RNF138, VPS11, UBQLN1, STX5, LONRF3, DACT1, MYLIP, XBP1, EGLN2, CSNK2A1, EDEM1, CAV1, ATPIF1, MSN, RAD23A, SIRT2, RNF40, DDB1, ITCH, PSMC1, TRIB3, TRIM32, RNF166]
GO:0045736;negative regulation of cyclin-dependent protein serine/threonine kinase activity;12.0;0.8933024483968273;0.8947715367885583;9.585964638073326;2927.1185870500644;6.375876246018314;0.09796802487286638;0.7741829203200885;[CDKN2D, CDKN1A, CDKN2C, CDK6, CASP3, PTEN, IPO7]
GO:0006898;receptor-mediated endocytosis;6.0;0.6799073451904818;0.6630739851853854;8.48339194818912;28.437470009997963;4.178651668682095;9.517765291732001E-4;0.536816753253722;[COLEC12, ITGB1, SCARB1, CD163L1, TFRC, ITGB2, CLTA, FNBP1L, RABEPK, LRP8, AGER, HSP90B1, CLN3, HSPH1, CLTCL1, AP2S1, APOL1, SCARF1, CAP1, FCER1G, DBNL, AMBP, SYK, CAV1, DNM2, GAK, SYNJ1, SNX17, CD9, HYOU1, FOLR2, PICALM]
GO:0006412;translation;7.0;0.8653626801206646;0.7836007053175329;9.510741216835738;402.5585345733233;4.39257856489138;0.01347327187300917;0.5755560373415389;[HBS1L, RPL3, MRPS16, MRPS36, RRBP1, MRPL37, RPS15, RPL36AL, HARS, RPL19, RPL39L, RPS9, NDUFA7, MRPS24, RPS7, MRPS18B, MRPS18A, SARS, RPL23A, RPSA, RPL3L, COPS5, TNIP1, RPL7L1, GUF1, RPL22L1, RPL29, MRRF, CPEB4]
GO:0006654;phosphatidic acid biosynthetic process;8.0;1.0;0.875;9.628524252492122;659.6112576846374;6.139487467954083;0.022076595183113425;0.6889736746265369;[AGPAT5, PLA2G12A, GPAM, DGKA, PLD1, AGPAT3]
GO:0048208;COPII vesicle coating;6.0;1.0;0.8231203125901445;9.628524252492122;62.43707956725794;5.6339389012889365;0.0020897128633926582;0.6112402100070131;[TRAPPC2, TRAPPC3, SEC13, TRAPPC2L, PDCD6, RAB1B, KLHL12, PPP6C, TFG, TBC1D20, TRAPPC6B, COL7A1, TMED2, STX5, SEC24C]
GO:0006888;ER to Golgi vesicle-mediated transport;6.0;1.0;0.8231203125901445;9.628524252492122;49.13394272044514;4.493869898942481;0.001644468845175705;0.5529370282083849;[DCTN6, DCTN5, COPB2, ARF4, COPA, DCTN2, DCTN4, PDCD6, RAB1B, GOSR1, DCTN3, KLHL12, TEX261, MIA3, RAB43, ACTR1A, SPAST, TFG, CAPZB, TMED2, STX5, TMED1, TMED7, TMED4, TRAPPC2, TRAPPC3, TMED9, TRAPPC2L, COG5, COG4, COG3, DDHD2, COG1, DYNLL2, SPTB, ARFGAP1, YIF1A, ARCN1, TBC1D20, TMEM115, VAPA, TRAPPC6B, GOLGB1, COL7A1, HYOU1, COPG2, SEC24C, SEC22C]
GO:0006405;RNA export from nucleus;8.0;0.7090535922965819;0.729526796148291;9.033817144745429;77.48498941580046;4.835431205071165;0.0025933528637837495;0.6222841766978864;[FYTTD1, SMG1, SEH1L, NUP107, POLDIP3, EIF4A3, BCCIP, CASC3, SMG5, NOL6, RPS15, ALKBH5, NXF3, PABPN1, U2AF2, TPR, NUP62, XPO5, NUP43, RAE1, UPF2, UPF1, RANBP3, CPSF3, CPSF2, NUP153, RPSA, THOC2, SRRM1, THOC6, NUP93, SLU7]
GO:0006409;tRNA export from nucleus;10.0;0.9326813400603323;0.8815816818910864;9.577230958104572;123.84512099227237;8.390779266560578;0.004144984746238629;0.8443458537639685;[NOL6]
GO:0001516;prostaglandin biosynthetic process;11.0;0.8933024483968273;0.8790801765280758;9.597752593825367;1037.183190875448;7.138016298065211;0.03471358799433119;0.7974674377644215;[CD74]
GO:0002606;positive regulation of dendritic cell antigen processing and presentation;6.0;0.8933024483968273;0.7697715367885581;9.427853557029971;55.28681003950749;7.8311634786251565;0.0018503997771236419;0.7236063770733796;[CD74, CCL19]
GO:0010469;regulation of signaling receptor activity;6.0;0.5916390046238794;0.6189398149020842;7.95454781892045;48.619731222684926;3.470798340732454;0.0016272586491059737;0.5006171011438312;[ITGB1, ERRFI1, CXCL6, GPI, CXCL9, GMFB, NCF1, PTEN, SECTM1, IL27, PARK7, METRNL, CXCL14, BICD1, PLAU, NPPA, IL12A, FAM3C, CAPN1, TIMP1, BUD31, PRKCE, PRKCD, FLT3LG, ADRA2C, GAL, SFRP2, IL23A, CHMP6, HBEGF, COPA, CCL3L1, EBI3, CLEC12B, AGER, CCL5, CCL3, CCL2, CCL19, CMTM7, UBE2I, TNFSF14, CCL20, CD70, BDNF, GDF1, NETO2, KLHL24, POMC, IL6, CXCL11, CDK5, PNOC, SCGB3A1, KCNK3]
GO:0090307;mitotic spindle assembly;8.0;1.0;0.875;9.628524252492122;186.05212215721153;6.193554689224359;0.006226997092562797;0.6917386748366816;[KIF3B, TUBGCP2, ZNF207, BCCIP, KPNB1, CLASP1, RAB11A, BIRC3]
GO:0016567;protein ubiquitination;9.0;0.6913464685778243;0.7419138594692012;8.996001693748612;153.79381005389072;3.300101264790787;0.005147340417060716;0.5650079573320931;[CCNF, UBE2D3, UBE3A, UBE2Z, UBE2L3, NPEPPS, HERC4, HERC1, CDC26, TRIM24, TRIM27, SKP2, C18orf25, ATXN7L3, MYLIP, RNF44, FBXO18, ARRDC1, FBXW11, UBE2E3, UBE4A, TRPC4AP, RC3H2, RNF40, KCTD10, ANAPC5, CBLL1, HIST1H2BC, RNF121, ANAPC13, CDCA3, KLHL14, MYCBP2, UBR4, DTX2, KLHL12, FBXO41, ANAPC11, VCPIP1, RNF213, MED30, UBD, HLTF, UBR5, RNF170, LONRF3, WDTC1, UBE2I, UBE2B, KLHL25, FANCL, LNPEP, KLHL24, MARCH6, MARCH3, CNOT4, RNF103, KLHDC8A, UBE2T, CDC16, FBXL3, PPP1R11, BRCA1, MED12, TRIM9, TRIM7, TRIM69, DTX3L, ZFP91, PJA2, DDB1, MED20, BIRC6, THOP1, RNF166, BIRC3, HIST1H2BO, PCNA, HIST1H2BJ, MGRN1, RNF38, NEDD8, NLRC4, RNF135, FZR1, ZNRF2, RMND5A, RAB40C, RNF138, RFFL, SASH1, RNF20, FEM1B, SYVN1, FBXL15, FBXL16, MIB1, ITCH, SPSB1, RFWD3, ASB8, TSPAN17, KBTBD2, TRIM32, ASB3, KBTBD8, TRIM33]
GO:0008360;regulation of cell shape;6.0;0.6763753087927167;0.6613079669865028;8.690254613899192;41.77565885716001;4.6590798152637145;0.0013981937062970905;0.5613858710120996;[WDR1, EPB41, SH3KBP1, WIPF2, LST1, ITGB2, WAS, WASL, CORO1A, CCL3, CCL2, TBCCD1, ANXA1, SEMA4D, MSN, CDC7, VRK1, VRK2, RHOC, RHOB, VIL1, MKLN1, CFDP1, FES, CDC42EP4, TAOK2, KIT, MYH9, RHOU, ALDOA, BRWD1, CSNK1G2, CSNK1G1]
GO:0032471;negative regulation of endoplasmic reticulum calcium ion concentration;11.0;0.9326813400603323;0.8987696223598284;9.57973408832269;289.7905246169981;7.697632086000634;0.009699028064390986;0.8260862151842345;[BAX]
GO:0045740;positive regulation of DNA replication;8.0;0.7671156992804218;0.7585578496402109;9.427853557029971;747.3070825002359;6.166155715036245;0.025011695518573164;0.6903374900225189;[STOML2, PCNA, CDK2, CDC7, CACYBP, HRAS, E2F7, E2F8]
GO:0000079;regulation of cyclin-dependent protein serine/threonine kinase activity;11.0;0.7866048967936545;0.8257314007264895;9.474373572664863;340.6851601099881;5.181953777545879;0.011402425712143147;0.6974343094988531;[CDKN2D, CDKN1A, CCNK, CDKN2C, CCNH, CCNF, PTEN, BCCIP, PKMYT1, PKD2, IPO7, CDC25A, CKS1B, CCNB1, CDK6, CCNE2, CCNE1, CASP3, MAPRE3, MNAT1, CDK5RAP3, CCNJL]
GO:0060907;positive regulation of macrophage cytokine production;9.0;1.0;0.896240625180289;9.628524252492122;311.82526325162985;7.9853141584524145;0.010436510936514811;0.8046099625986299;[CD74]
GO:0001961;positive regulation of cytokine-mediated signaling pathway;7.0;0.7192862368539868;0.710562483684194;8.965230035081857;244.22079422365863;5.948432231191374;0.008173850198220667;0.6551224661907153;[CD74, GFI1, CPNE1, CD300LF, TRIM32, LSM14A, PAFAH1B1]
GO:0070262;peptidyl-serine dephosphorylation;8.0;1.0;0.875;9.628524252492122;179.24922260518233;7.292166977892469;0.005999310166768488;0.747921758369865;[PPP2CA, PPP2R2A, PPP1CA]
GO:0006977;DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest;11.0;1.0;0.9324289523296623;9.628524252492122;888.119660647831;5.75172193694532;0.0297245657860804;0.7265722796674696;[BTG2, CDKN1A, PCNA, CNOT10, CNOT4, CNOT6, CCNB1, TFDP1, CNOT7, TFDP2, CNOT1, CNOT3, CDK2, CASP2, EP300, BAX, CNOT8, GTSE1, E2F7, E2F8]
GO:0030968;endoplasmic reticulum unfolded protein response;5.0;0.8653626801206646;0.7229223519212526;9.387362195675234;54.36536464462378;5.142344639450834;0.0018195598290039001;0.5532207558659172;[FKBP14, DERL3, DERL2, HSP90B1, EXTL2, LMNA, SSR1, CCL2, SULT1A3, CDK5RAP3, ZBTB17, MBTPS1, XBP1, WFS1, EDEM1, SYVN1, EIF2AK3, EIF2S1, ARFGAP1, YIF1A, ERN1, CREB3, TBL2, CTDSP2, DNAJB11, TPP1, HYOU1, TLN1, ATF4, RNF121]
GO:0001844;protein insertion into mitochondrial membrane involved in apoptotic signaling pathway;9.0;1.0;0.896240625180289;9.628524252492122;197.68572259573045;7.9853141584524145;0.006616363229679372;0.8046099625986299;[BAX]
GO:0071231;cellular response to folic acid;8.0;1.0;0.875;9.628524252492122;595.1168603127351;9.083926447120524;0.019918025744265135;0.839552420951524;[FOLR2]
GO:0000082;G1/S transition of mitotic cell cycle;5.0;1.0;0.7902410118609202;9.628524252492122;42.752976916212816;5.142344639450834;0.0014309036622044387;0.5532207558659172;[ITGB1, PRIM2, CDKN1A, USP37, MAX, GMNN, MCM10, PPP6C, GPR132, PPAT, MYC, SKP2, CDKN2D, CDKN2C, RANBP3, CDC7, CDC25A, POLE4, WEE1, POLA2, CDK6, CCNE2, CCNE1, POLE2, CDK2, POLE3, MCM5, RHOU, MCM6, MNAT1, MCM2]
GO:0034644;cellular response to UV;7.0;0.7980440201809971;0.7499413753476991;9.223059144383958;66.19362175939281;5.420364800990877;0.0022154409498949313;0.628117073252615;[CREBBP, CDKN1A, PCNA, MME, RHBDD1, XPC, PTPRK, EIF2S1, CDC25A, AQP1, MAPK13, YY1, DDB1, HIST3H2A, MYC, HYAL2, TP53INP1, PBK, EP300, BAX, PPID, POLH, ATF4]
GO:0071356;cellular response to tumor necrosis factor;6.0;1.0;0.8231203125901445;9.628524252492122;81.6500655361772;4.973052582947213;0.0027327542132076126;0.5774424529526606;[ABCC2, CCL3L1, CCL20, CIB1, RORA, BRCA1, THBS1, TANK, NFKB1, RELA, SFRP1, BAG4, CCL5, HYAL2, CCL3, CCL2, RIPK1, CCL19, MAP3K5, PCK2]
GO:0045071;negative regulation of viral genome replication;8.0;0.8933024483968273;0.8216512241984136;9.474373572664863;85.23964546052278;5.8067817141283475;0.0028528942228632634;0.6719590869034888;[ILF3, CCNK, APOBEC3F, VAPA, TNIP1, APOBEC3H, CCL5, BANF1, ZC3HAV1, APOBEC3A]
GO:0007281;germ cell development;4.0;0.8653626801206646;0.6826813400603323;9.34084218004034;71.68419734523428;4.759793790865545;0.0023992055735558276;0.4934160758179115;[SPAG6, ODF2, STRBP, H3F3A, CIB1, AFF4, IQCG, TIAL1, ING2, KIT, RARA, BAX, HORMAD1, PAFAH1B1]
GO:0035970;peptidyl-threonine dephosphorylation;8.0;1.0;0.875;9.628524252492122;179.24922260518233;7.004484905440688;0.005999310166768488;0.7332096838060964;[PPP2CA, DUSP5, PPM1G, PPP1CA]
GO:0070936;protein K48-linked ubiquitination;11.0;1.0;0.9324289523296623;9.628524252492122;157.60047254366168;5.8650506222523235;0.00527474598481953;0.7323679139043926;[ITCH, UBE2B, DTX3L, UBE2T, UBE2E3, UBR5, UBE2D3, SYVN1, UBE3A, RFFL, MARCH6, TRIM32]
GO:0032461;positive regulation of protein oligomerization;7.0;0.8653626801206646;0.7836007053175329;9.5544162803384;141.07486917829812;6.599019797332524;0.004721648912258263;0.6883935445785896;[HRK, BAX, BID, RHOC]
GO:0051085;chaperone cofactor-dependent protein refolding;5.0;1.0;0.7902410118609202;9.628524252492122;21.14140270213274;6.409777797693995;7.075837224132252E-4;0.618037346520142;[GAK, DNAJB1, CD74, TOR1A, HSPH1, DNAJC7, DNAJB5, HSPA6, BAG1, HSPE1]
GO:0046604;positive regulation of mitotic centrosome separation;10.0;1.0;0.9152410118609203;9.628524252492122;603.270018576253;7.8311634786251565;0.020190904613979026;0.8157270763441555;[NSFL1C, RANBP3]
GO:0006513;protein monoubiquitination;10.0;0.8653626801206646;0.8479223519212526;9.574457031221845;155.4032479663248;5.649939242635378;0.005201206855589802;0.704179167478338;[DDB1, RNF20, UBE2B, DTX3L, MGRN1, FANCL, UBE2T, UBE2D3, KLHL12, KBTBD8, ATXN7L3, RNF40]
GO:0006511;ubiquitin-dependent protein catabolic process;8.0;0.7369933605727446;0.7434966802863723;9.190269321560967;156.4521708431119;3.582668236575797;0.005236313360306564;0.5582178202295975;[CCNF, UBE2D3, BUB1B, UBE3A, UBE2Z, UBE2L3, PSMD8, PSMD7, PSMD4, PSMD2, CDC26, SKP2, C18orf25, USP8, MYLIP, RNF44, FBXO18, ARRDC1, FBXW11, UBE4A, KCTD2, TRPC4AP, KCTD5, RNF40, KCTD10, TBL1XR1, ANAPC5, RNF121, UBR4, ANAPC11, HSP90B1, CCNB1, RNF213, UBD, UBR5, USP51, XBP1, UBE2I, UBE2B, KLHL25, WFS1, EDEM1, ERLIN2, BTBD6, MARCH6, NSFL1C, CYLD, RNF103, NPLOC4, CDC16, FBXL3, USP36, USP37, USP38, PPP1R11, USP32, USP34, KIF14, TRIM9, USP46, SEC13, DTX3L, RAD23A, VPS37A, SIRT2, DDB1, PSMA1, MAN1B1, USP41, USP13, DERL3, VPS4B, RNF38, USP12, DERL2, NEDD8, PSMB10, PSMA7, ARNTL, AMN1, FZR1, ZNRF2, PSMB5, RMND5A, TP53INP2, PSMB1, UBQLN1, RFFL, RNF20, RANBP3, LRRC29, SYVN1, FBXL15, FBXL16, KBTBD4, ITCH, SPSB1, PSMC1, TRIM32, MAD2L1]
GO:0090090;negative regulation of canonical Wnt signaling pathway;8.0;0.7866048967936545;0.7683024483968273;9.283683766200392;236.99226377157444;4.932886541221878;0.00793191778924446;0.6272680471207706;[TLE4, TCF7L2, HDAC1, CAV1, CHD8, FZD6, KLHL12, PRICKLE1, STK4, STK3, AES, CYLD, SFRP1, SFRP2, RAPGEF1, DVL3, EMD, DACT1]
GO:0006509;membrane protein ectodomain proteolysis;7.0;0.8933024483968273;0.7975705894556142;9.446202695698167;50.748517158788495;6.781341354126479;0.0016985071986044009;0.6977174774718518;[P2RX7, PSEN2, MYH9]
GO:0014808;release of sequestered calcium ion into cytosol by sarcoplasmic reticulum;16.0;1.0;1.0;9.628524252492122;562.8564541266966;7.8311634786251565;0.01883829898169905;0.9004860644832351;[CCL3]
GO:2000503;positive regulation of natural killer cell chemotaxis;11.0;1.0;0.9324289523296623;9.628524252492122;1000.5321764499969;7.9853141584524145;0.03348691152528284;0.8407982897480031;[CCL5, CCL3, CXCL14]
GO:0071222;cellular response to lipopolysaccharide;6.0;1.0;0.8231203125901445;9.628524252492122;237.99812851129587;4.786641040901733;0.007965583176863442;0.5679093580234316;[CXCL6, CD40, CXCL9, CEBPE, GFI1, CD80, RELA, PABPN1, NLRP7, TBXA2R, ABL1, NLRP3, CCL2, IL12A, HAVCR2, UPF1, XBP1, ABCC2, CCL20, PDCD1LG2, NFKB1, BCR, IL6, CXCL11, TNIP1, TNIP2, RARA, NFKBIB]
GO:0045087;innate immune response;4.0;0.6799073451904818;0.5899536725952409;8.162187183698695;26.470038109745843;3.422703586883119;8.859283540455166E-4;0.42503722060519694;[NCF1, NCF2, CRISP3, DEFB1, IL27, LYST, IPO7, PIK3CG, PPP6C, C1QBP, TRIM27, HAVCR2, MAP3K5, FGA, MAP4K2, CR2, FCER1G, ANXA1, DTX3L, SYK, WRNIP1, RNASE3, IRAK4, TMEM173, SIRT2, IL23A, ELF4, PSPC1, TRIM14, TLR7, TLR10, CFB, HIST1H2BC, ANKRD17, COLEC12, HIST1H2BJ, CFH, CEBPG, NLRC4, ZC3HAV1, LILRA2, CORO1A, AGER, RELA, C2, C3, RNF135, CLEC7A, PRDX1, NLRP2, ABL1, SLAMF7, NLRP3, CSK, APOL1, XRCC6, PPP1R14B, APOBEC3F, APOBEC3H, XRCC5, NONO, MX2, NFKB1, ANKHD1, CYLD, ITCH, POLR3B, POLR3C, FES, TREML4, POLR3E, PTX3, PTPN6, SERINC3, TRIM32, CD244, APOBEC3A, C1QC]
GO:0097711;ciliary basal body-plasma membrane docking;5.0;1.0;0.7902410118609202;9.628524252492122;21.38880323109876;5.223196736079928;7.158639954716971E-4;0.5573555358475362;[DCTN2, ODF2, RAB3IP, DCTN3, TUBG1, CKAP5, RAB11A, ACTR1A, CENPJ, CEP70, MKS1, FGFR1OP, MAPRE1, CLASP1, PAFAH1B1]
GO:0048597;post-embryonic camera-type eye morphogenesis;7.0;1.0;0.8509193652572005;9.628524252492122;48.053913514796484;8.67846133901236;0.0016083212396258246;0.7947362817240173;[BAX]
GO:1990117;B cell receptor apoptotic signaling pathway;11.0;1.0;0.9324289523296623;9.628524252492122;271.8768765826067;9.777073627680469;0.009099474385916458;0.9324289523296623;[BAX]
GO:0070374;positive regulation of ERK1 and ERK2 cascade;11.0;0.9326813400603323;0.8987696223598284;9.604993755081928;1178.864923326294;4.330336256014159;0.03945554807418015;0.6538825498434562;[CCL3L1, PTEN, CIB1, PTPN22, AGER, IGF1R, RAP1B, CCL5, ABL1, CCL3, CCL2, CCL19, HRAS, PDE8A, EPHB4, HAVCR2, PDGFRB, FGA, CD74, ANGPT1, CCL20, RYK, FGG, GPR55, CD4, KARS, KIT, RAPGEF1, TEK, EPHA1, MET]
GO:0035723;interleukin-15-mediated signaling pathway;7.0;1.0;0.8509193652572005;9.628524252492122;30.19135422731818;7.212124270218933;0.00101047745553359;0.7197477358342742;[IL15RA, CD4, IL2RG]
GO:0071347;cellular response to interleukin-1;6.0;1.0;0.8231203125901445;9.628524252492122;81.6500655361772;5.446340287394138;0.0027327542132076126;0.6016464081682054;[UPF1, CD40, ABCC2, CCL3L1, CCL20, FGG, RORA, TANK, NFKB1, RELA, MAPK13, YY1, SFRP1, NLRP7, CCL5, HYAL2, CCL3, CCL2, CCL19]
GO:0071346;cellular response to interferon-gamma;6.0;1.0;0.8231203125901445;9.628524252492122;81.6500655361772;5.266214121163619;0.0027327542132076126;0.5924347476504533;[ACTR2, GSN, CCL3L1, CCL20, WAS, VPS26B, RAB43, RAB20, CCL5, CDC42EP4, CCL3, CCL2, CCL19, IL12RB1, GAPDH, HLA-DPA1]
GO:2000502;negative regulation of natural killer cell chemotaxis;11.0;1.0;0.9324289523296623;9.628524252492122;1002.759017369874;9.083926447120524;0.03356144188684441;0.8969813732811862;[CCL2]
GO:0060761;negative regulation of response to cytokine stimulus;5.0;0.6954798709641801;0.6379809473430103;8.438940185618286;40.831621184480156;5.734022359845919;0.001366597614971242;0.5834791820027497;[IL6, CNOT7, HIST1H2BJ, CCL5, CAV1, GPS2, RFFL, AES]
GO:0035684;helper T cell extravasation;9.0;0.8933024483968273;0.8428918493787028;9.474373572664863;63.467001142674015;9.777073627680469;0.002124183411652594;0.896240625180289;[CCL2]
GO:0043507;positive regulation of JUN kinase activity;13.0;0.8653626801206646;0.8952363048279688;9.582714716460828;4931.413721535565;5.459585514144159;0.16504997927558432;0.7417584218576596;[ERN1, MAP4K2, DBNL, SYK, DVL3, RIPK1, CCL19, MAPK8IP3, AGER, ARHGEF5, SASH1, MAP3K5]
GO:0007093;mitotic cell cycle checkpoint;7.0;0.7140352122741334;0.7079369713942671;9.0094850440859;132.2042645947957;5.142344639450834;0.0044247577598742595;0.6138991092621975;[FANCI, TOP2B, TIPIN, ZWILCH, INTS3, PRCC, DONSON, MAD2L1BP, BUB1B, XPC, BRCA1, ZWINT, CENPF, WEE1, RFWD3, TPR, TAOK2, CDK2, ZNF207, KNTC1, TOPBP1, HRAS, CDK5RAP3, MAD2L1]
GO:0050718;positive regulation of interleukin-1 beta secretion;11.0;1.0;0.9324289523296623;9.628524252492122;998.8167007681584;6.518977089658987;0.033429496098039586;0.7658097438582601;[P2RX7, NLRP12, NLRP7, NLRP2, CCL3, NLRP3, CCL19]
GO:0034351;negative regulation of glial cell apoptotic process;8.0;0.9326813400603323;0.8413406700301662;9.5544162803384;104.32654737607098;7.697632086000634;0.003491715652880169;0.7686572628545723;[PRKCD, CCL2]
GO:1901620;regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning;7.0;0.8933024483968273;0.7975705894556142;9.4949928598676;103.99615894785289;7.697632086000634;0.003480657849517991;0.7445766281117727;[MKS1]
GO:0048515;spermatid differentiation;4.0;1.0;0.75;9.628524252492122;60.59721651971341;8.16763571524637;0.002028134302960584;0.6676932703116032;[RHBDD1, TMEM119, BAX]
GO:0048754;branching morphogenesis of an epithelial tube;6.0;0.7436939687323844;0.6949672969563367;8.8813098506619;51.7127811195946;4.956792062075433;0.0017307802455913577;0.5766108891590862;[LAMA5, RBM15, SFRP2, MYC, TIMELESS, MKS1, KRAS, PKD2, STK4, MET, RASIP1, PPP1CA]
GO:0008625;extrinsic apoptotic signaling pathway via death domain receptors;7.0;0.9326813400603323;0.8172600352873667;9.523163736834295;52.44533375847466;6.311337724880743;0.0017552981231601008;0.6736814700148209;[CASP8, DIABLO, BAG3, TRADD, TNFRSF10B, BAX, TNFRSF10A, BID, DEDD]
GO:0042775;mitochondrial ATP synthesis coupled electron transport;7.0;1.0;0.8509193652572005;9.628524252492122;33.34232067890278;7.57984905034425;0.0011159374669824286;0.738553198190834;[NDUFV3, BID, TAZ]
GO:0006687;glycosphingolipid metabolic process;7.0;0.6763753087927167;0.6891070196535589;9.040737587590003;147.45961877692685;5.734022359845919;0.004935340735422783;0.64415753539903;[GALC, GLTP, CTSA, UGT8, CLN3, ALDH5A1, KIT, BAX, GBA2, SUMF1]
GO:0048087;positive regulation of developmental pigmentation;4.0;0.7307253602413294;0.6153626801206646;8.465373442686442;21.72088911100368;7.697632086000634;7.269786110142264E-4;0.6436572628545723;[BAX]
GO:0001666;response to hypoxia;5.0;0.811012628672052;0.6957473261969462;9.117698628726131;21.16160540946;4.1860866471696125;7.082598888462125E-4;0.5043176776701113;[BECN1, SUV39H1, ABCB4, PTEN, PSEN2, ITPR2, RORA, THBS1, AQP3, AGER, TM9SF4, HSP90B1, AQP1, NPEPPS, ALKBH5, CCNB1, PLAU, MYC, FUNDC1, CASP3, UCP3, NPPA, LMNA, UBQLN1, CAPN2, EP300, SCAP, ATP7A, CREBBP, EGLN2, ENDOG, ITGA2, CAV1, PRKCE, ARNT, AGTRAP, SIRT2, NR4A2, SFRP1, TBL2, DDIT4, CAT, HYOU1, TEK, CD24, PAM, KCNK3]
GO:0010818;T cell chemotaxis;8.0;0.8436909121759173;0.7968454560879586;9.446202695698167;127.60944988880927;7.292166977892469;0.004270973446729658;0.747921758369865;[CXCL9, CXCL11, CCL3, PIK3CG, CCR2]
GO:0006559;L-phenylalanine catabolic process;10.0;0.9326813400603323;0.8815816818910864;9.59953671561887;1267.4995185646956;7.379178354882098;0.04242206821085258;0.7926125360964777;[PCBD1, HPD]
GO:0033137;negative regulation of peptidyl-serine phosphorylation;10.0;0.8933024483968273;0.861892236059334;9.56398573135455;780.3281191277907;6.518977089658987;0.026116879897493853;0.7486218033895181;[RASSF2, CAV1, DDIT4, PAQR3, BAX]
GO:0019886;antigen processing and presentation of exogenous peptide antigen via MHC class II;5.0;1.0;0.7902410118609202;9.628524252492122;42.20009821028515;5.192106149009898;0.0014123993094755708;0.5557655617789146;[DCTN6, DCTN5, DCTN2, DCTN4, DCTN3, CLTA, KLC1, KIF15, HLA-DMA, ACTR1A, HLA-DMB, ACTR1B, KIF3B, CAPZB, AP1G1, AP2S1, CTSE, HLA-DQA1, HLA-DPA1, AP1M1, CD74, LAG3, SEC13, FCER1G, AP1B1, KIF23, DYNLL2, DNM2, CENPE, KIF4A, HLA-DPB1, KIF2C, HLA-DRB3, SEC24C, HLA-DQB1]
GO:0035556;intracellular signal transduction;5.0;0.5140152493238541;0.5472486365228473;6.9204740513899115;23.17027026302992;2.4005655013542495;7.75488093814194E-4;0.41300604323788886;[NCKAP1, OXTR, TESK2, CALML4, RPS6KA4, PREX1, RPS6KA5, RPS6KA2, MYC, ARL6IP5, GTSE1, PDK1, PRKCE, PAQR3, PRKCD, BCR, NISCH, TIAM2, DEPDC1B, KARS, DDIT4, TRIB3, ATF4, PAXIP1, CRHR1, ABR, NUAK1, RHOT2, RHOT1, PPP4C, RRAS, TP53BP2, STK38L, CCR10, SULT1A3, PAG1, XBP1, SETDB1, EIF2AK3, RAB27B, SETX, CCDC88A, CYLD, COL1A2, CALM3, CALM1, RGL1, CD24, CALM2, BTG2, CDKN1A, CD40, ARHGAP1, BRCA1, BBC3, AKAP13, AKAP11, NKIRAS1, C1QBP, CTSH, HRAS, TEAD2, RAB8B, CCR2, DUSP5, MAP4K2, DBNL, RIPK3, SPHK1, TMEM173, RHOC, GMIP, GFRA2, SIRT2, VAV1, CIT, VAV2, RHOB, ITPKB, GAL, CDC42EP4, KIT, DEPDC1, RAPGEF1, TAX1BP3, ARHGEF1, TLR7, RHOU, ARHGEF5, EXOC1, HBEGF, PTGER4, PCNA, GPS1, ADCY4, WAS, GPS2, TANK, RELA, PPP2CA, PERP, BID, MAP3K3, MAP3K1, GSN, CCL20, MYO9B, RAB11A, ITCH, CAMK4, TAOK2, PKN2, CAMK1, TJP2, RAB3B, DGKD, RTKN, DGKA, CD80, RAB3D, SIRPG, IL5RA, DEFB1, PARK7, IGF1R, RAB43, DOCK11, ARHGDIB, CFL1, EP300, SNIP1, NEK1, MAP3K5, IFNAR2, PDGFRB, USP8, IGFBP5, FBXW11, ERN1, DOK2, RAB35, ELMO1, RAB38, KPNB1, CARD11, RAB5C, DIABLO, CLEC16A, PSEN2, ITPR2, RASGRP2, STK4, PLD1, KRCC1, RASGRP4, STK3, RASGRP3, RAP1B, CCNB1, ZMAT1, TBXA2R, STK38, ABL1, DVL3, MBP, RIPK1, ECT2, RAB6A, MARK2, PRNP, RAB4B, IFT122, TNFRSF10B, CNOT10, CORO2A, NFKB1, NFKBIA, CNOT4, CNOT6, IRAK1BP1, CNOT7, ARHGAP30, SH3BP5L, PTPRA, CNOT1, GNAQ, RCAN3, BCL3, CNOT3, CDK2, PLEKHM1, NMUR1, CNOT8, LSM14A, BCAR3, MCTP1, PRKCSH, MAST3, YWHAB, DOCK8, TRADD, PTEN, ATP2A2, PKD2, PIK3CG, POLB, FLCN, CASP8, RASGEF1A, CASP3, CASP2, TLK1, ITGAV, ARHGEF11, KSR1, OXSR1, IRAK4, MASTL, ADRA2C, SPTB, TGFBR1, PJA2, TFDP1, ALS2, TFDP2, ADORA2A, PIK3C3, LCP2, LCP1, DOCK2, MET, BIRC3, PPP1R15A, CAMK2D, RGS19, ROCK2, TUFT1, RAB1B, IL2RG, RAB21, FZR1, GNG2, RAB20, PABPN1, RAB40C, CCL5, TIFA, MKNK2, CCL3, CCL2, NCAM1, ZNF622, RAB28, SH2B3, E2F7, SH2B2, E2F8, ARFGEF2, ANGPT1, CDC5L, TSHR, MAPK13, SNRK, P2RX4, TNIP2, ASB8, RAB13, RAB18, BAX, CCM2, KRAS, PTPN6, TEK, ASB3]
GO:0070206;protein trimerization;6.0;0.8933024483968273;0.7697715367885581;9.405380701177911;42.032160359171186;5.8650506222523235;0.00140677858073304;0.6230592741648748;[CD74, COL1A2, PNPT1, NUP62, ITLN1, PKD2L1, TRIM27, CLYBL]
GO:0043518;negative regulation of DNA damage response, signal transduction by p53 class mediator;9.0;0.9326813400603323;0.8625812952104552;9.585964638073326;408.0520127891259;7.138016298065211;0.013657133645082668;0.7612791106150483;[CD74, SENP2]
GO:0050729;positive regulation of inflammatory response;7.0;0.657518819034173;0.679678774774287;8.587070377663961;125.85203775116636;4.973052582947213;0.0042121544440509905;0.6052415056197167;[PTGER4, SUCNR1, FCER1G, CCL3L1, ITGA2, PARK7, PIK3CG, MAPK13, NFKBIA, C3, VAMP8, NLRP12, IL6, KARS, TNIP1, IL23A, HYAL2, NPPA, CCL3, TLR7, TLR10, GPSM3, CCR2]
GO:1902166;negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator;11.0;1.0;0.9324289523296623;9.628524252492122;2131.9864477698584;7.212124270218933;0.07135566774362433;0.8012573229067359;[BCL2L12, CD74, ING2]
GO:2000095;regulation of Wnt signaling pathway, planar cell polarity pathway;8.0;0.7192862368539868;0.7346431184269935;9.242861771680136;111.49249333198095;7.212124270218933;0.003731553415091816;0.7438283705770736;[SFRP1, SFRP2, ABL1, MKS1, DACT1]
GO:0051260;protein homooligomerization;6.0;0.8933024483968273;0.7697715367885581;9.405380701177911;42.032160359171186;4.056761851073058;0.00140677858073304;0.5305833023127396;[KCNG1, CRTC2, DGKD, PKD2L1, PKD2, CLYBL, GLS, PPAT, PDCD6IP, KCND1, FCER1G, RIPK3, GPX3, DCXR, ATPIF1, KCTD2, KCTD5, ALDH5A1, KCTD10, CAT, KCTD14, CHMP4B, ALDOA, ACPP, COLEC12, ITLN1, KCNA3, NLRC4, SAMHD1, ACACA, SPAST, RXRA, RNF213, RIPK1, PCBD1, ECT2, BID, VASP, POLQ, PRNP, TOR1A, PNPT1, CAV1, EIF2AK3, MARCKS, RAD51, P2RX4, EHD4, IMPDH2, BAX, PAM]
GO:0008630;intrinsic apoptotic signaling pathway in response to DNA damage;7.0;0.9326813400603323;0.8172600352873667;9.55953138100517;84.23129647150353;5.54296712308321;0.002819145689655962;0.6343869617060081;[POLB, CDKN1A, BCL3, DDIT4, ABL1, CASP2, EP300, BAX, BRCA1]
GO:0008635;activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c;14.0;1.0;0.9759193652572005;9.628524252492122;734.4853933519539;7.8311634786251565;0.024582565121551242;0.8764054297404356;[DIABLO, BAX]
GO:0030890;positive regulation of B cell proliferation;9.0;1.0;0.896240625180289;9.628524252492122;506.1565706318756;6.063501560976162;0.016940604907709607;0.706328376990269;[CD74, CDKN1A, CD40, TFRC, FCRL3, NCKAP1L, CARD11]
GO:0016485;protein processing;6.0;0.6519675769143192;0.6491041010473041;8.320191432841943;99.81063536400724;4.720827822332161;0.0033405721418933456;0.564543666965156;[CYFIP2, STOML2, PSEN2, ECE2, CLN3, CASP8, PLAU, PERP, CASP3, CAPN2, CASP2, CTSH, LONP2, PMPCB, CTSE, SEC11A, SEC11C, FGA, MME, RHBDF2, FGG, P2RX7, SPCS2, PIK3C3, METAP2]
GO:0071407;cellular response to organic cyclic compound;5.0;0.5310727365277519;0.5557773801247963;7.0299582842316;63.0333181336412;3.907776714546695;0.0021096684316296343;0.4900848947730398;[ERRFI1, RORA, BRCA1, PKD2, ELK1, AACS, PIK3CG, UBE2L3, AQP1, CASP8, SIN3A, CASP3, ACTR2, USP8, ABCC2, ANXA1, IGFBP5, ITGA2, SERPINF1, TMEM173, SIRT2, DNM2, SFRP1, XRN1, DDIT4, RAPGEF1, ATF4, COLEC12, ROCK2, ABCB4, ITPR2, LRP8, HSP90B1, RAP1B, CCNB1, GNG2, CCL5, ABL1, CCL3, CCL2, RAE1, SULT1A3, PCK2, JUP, CAV1, ATP2B4, MSN, CDC5L, GDAP1, NFKB1, SSH1, SOD1, NFKBIA, P2RX7, RAD51, P2RX4, FOLR2, EZH2]
GO:0051259;protein complex oligomerization;5.0;0.7763722522362496;0.6784271379790451;9.089527751759436;40.42272244673708;3.6012063575747084;0.0013529121422039536;0.47440687246051283;[DPAGT1, KCNG1, CRTC2, DGKD, YWHAB, TRADD, PKD2L1, IKZF1, PKD2, CLYBL, GLS, IGF1R, PPAT, NUP62, TRIM27, HRAS, TGM3, HBZ, PDCD6IP, KCND1, FCER1G, TRAPPC2L, RIPK3, GPX3, DCXR, ATPIF1, HBE1, KCTD2, PRKAB1, KCTD5, GCHFR, ALDH5A1, KCTD10, CAT, KCTD14, CHMP4B, ALDOA, ACPP, BIRC3, COLEC12, STOML2, CAMK2D, OAT, AHNAK, ITLN1, KCNA3, NLRC4, SAMHD1, HSD17B8, ACACA, BAG4, SPAST, RXRA, RNF213, CCL5, NLRP3, RIPK1, PCBD1, ECT2, BID, TRPM6, S100A10, VASP, POLQ, PRNP, CD74, RRM1, SEPT11, XRCC6, CPSF6, TOR1A, PNPT1, JUP, CAV1, EIF2AK3, DHRS4, P2RX7, MARCKS, COL1A2, RAD51, P2RX4, EHD4, IMPDH2, BAX, TEK, FARSA, PAM]
GO:1905563;negative regulation of vascular endothelial cell proliferation;8.0;1.0;0.875;9.628524252492122;108.34661668819432;8.390779266560578;0.0036262637549294456;0.8041048419030481;[CCL2]
GO:0040014;regulation of multicellular organism growth;5.0;0.8933024483968273;0.736892236059334;9.377209824211215;36.77819272999274;5.557565922504363;0.0012309330124483187;0.5744551915910391;[BBS2, VIL1, ATRN, NIPBL, SGPL1, GPAM, CHD7, SH3PXD2B, SOD1]
GO:0034453;microtubule anchoring;6.0;0.811012628672052;0.7286266269261705;9.223059144383958;33.1981629444775;6.558197802812269;0.0011111126373447525;0.6585068532133508;[NIN, CEP350, BCCIP, FGFR1OP, BICD1, CLASP1]
GO:0008285;negative regulation of cell proliferation;5.0;0.5619039856592722;0.5711930046905564;7.31175452450612;43.614270733588945;3.2818080717434612;0.0014597303911579066;0.4580728292695636;[CDKN1C, BTG2, CDKN1A, BMPR2, BTG1, CD80, LST1, SIRPG, PTEN, CIB1, PTPRK, COMT, PKD2, FLCN, ING2, ADORA3, RPS6KA2, MYC, CASP3, FNTB, NUP62, TRIM24, TIMP2, CTLA4, IL12A, JARID2, HRAS, EMD, RBM5, HAVCR2, KLF10, KLF11, KLF13, IGFBP5, SERPINF1, ATPIF1, EMP3, PDCD1LG2, SIRT2, TGFBR1, NME1, SFRP1, TWSG1, GAL, TFDP1, SFRP2, KARS, ADORA2A, RAPGEF1, RARA, TAX1BP3, B4GALT7, GAS8, SF1, BECN1, CCL3L1, STK4, THBS1, STK3, TMEM127, TP53INP1, LMNA, MFN2, CCL2, CSK, E2F7, TFAP2A, CDKN2D, ZBTB17, PRNP, CDKN2C, CAV1, IDH2, GLMN, EAF2, IFT122, WDR13, PER2, ITCH, IL6, CDK6, CNOT7, FAP, TMEM115, NFIB, CD9, PEMT, BAX, MNDA, SPRY1, PTPN6, CNOT8, TRIM32]
GO:0008284;positive regulation of cell proliferation;5.0;0.5587538620495764;0.5696179428857084;7.270369308343265;43.45254999490143;2.9881018846882994;0.0014543177435732513;0.44305268120482816;[TFRC, CD80, PDCD6, SIRPG, CCNF, CIB1, IGF1R, AQP1, TIAL1, PPP1CC, MYC, FNTB, SOX8, IL12A, CAPN1, SKP2, MAP3K5, PDGFRB, RPS9, TIPIN, CSNK2A1, IGFBP5, FLT3LG, RUNX2, ERN1, SFRP1, SFRP2, CCNE2, IL23A, CCNE1, EPHA1, CARD11, FOXG1, EBI3, NOLC1, CORO1A, AGER, CCNB1, ABL1, SSR1, NCKAP1L, XBP1, CDC7, CCDC88B, CNOT6, IL6, CDK6, CNOT7, SP1, CDK2, TMEM119, FGFR1OP, CNOT8, MNAT1, CD24, IL7R, CCNJL, ITGB1, CDKN1A, CD40, WDR48, BMPR2, ITGB3, CDCA7L, KIF14, PTEN, LAMC1, HOXC10, LBH, CTSH, ITGAV, TIMP1, ATP7A, HRAS, CCR2, HLA-DPA1, HAVCR2, ANXA1, SYK, SPHK2, ITGA2, SPHK1, FCRL3, TBC1D8, ARNT, PDCD1LG2, IRAK4, TGFBR1, NME1, KIT, RARA, BIRC6, EAPP, HBEGF, CDC123, HDAC1, DERL2, CRIP2, THBS1, RELA, FZR1, HLA-DMB, CCL5, MFN2, CCL19, IL12RB1, DISC1, TBX1, MAP3K3, CD74, TSHR, PDCL3, CD4, GPAM, HLA-DPB1, KRAS, PTPN6, FAM98A, TEK, FOLR2, SSBP3]
GO:0060548;negative regulation of cell death;5.0;0.5408746917014966;0.5606783577116685;7.270369308343265;41.94029430001592;2.875336421023895;0.0014037039064071987;0.4372858501489002;[CIB1, PARK7, UBE2Z, TM7SF3, IGF1R, AQP1, MYC, CFL1, SOX8, PDE8A, EPHB4, IER3, PDGFRB, CSNK2A1, SERPINF1, PRKCD, FLT3LG, THOC6, NUP93, SFRP1, CFDP1, SFRP2, PPIF, VDAC2, CHMP4B, ADNP, EPHA1, PPID, ATF4, LRPAP1, ABCB4, PSEN2, CORO1A, MTDH, HSP90B1, BCL2L12, BAG4, HSPH1, BAG3, BAG1, ABL1, NCKAP1L, RIPK1, NTSR1, SULT1A3, ATG5, TFAP2A, PRNP, PRELID1, XBP1, UBE2B, CBX4, TNFSF14, WFS1, BDNF, NONO, RHBDD1, CAV1, PYCR1, TNFRSF10B, TNFRSF10A, NFKB1, SETX, VIL1, NFKBIA, NR4A2, IL6, SON, COPS5, CDK5, QARS, BCL3, HYOU1, MNAT1, IL7R, CPEB4, AVEN, ITGB1, ARF4, BTG2, CDKN1A, DOCK8, TRADD, KIF14, PTEN, BRCA1, AATF, PIK3CG, ING2, CASP8, NNT, SIN3A, CASP3, NUP62, CASP2, CTSH, ITGAV, TIMP1, HRAS, TEAD2, TSC22D4, FGA, DFFA, FCER1G, ANXA1, SPHK2, PARP2, SPHK1, TSC22D3, FGG, PLAUR, SERPINB9, CACYBP, YWHAZ, TGFBR1, DDB1, ITPKB, CREB3, ADORA2A, PTRH2, KIT, CAT, TMBIM1, RARA, BIRC6, MET, BIRC3, BECN1, HDAC3, HDAC1, VPS4B, NLRC4, THBS1, RELA, UNG, CLN3, CCL5, LMNA, CCL2, CCL19, RFFL, SNCB, BID, DCPS, TBX1, CDKN2D, TCF7L2, CD74, ANGPT1, SEMA4D, EYA2, RYK, SYVN1, SOD1, ITCH, GPAM, TNIP2, PSMC1, BAX, KRAS, ERCC5, PDCD1, TEK, CIAPIN1, TRIM32, MAD2L1]
GO:0046598;positive regulation of viral entry into host cell;8.0;0.9326813400603323;0.8413406700301662;9.548481544818586;85.02443603688559;7.57984905034425;0.0028456913571300335;0.7626338329336335;[CD74, CD4]
GO:0045944;positive regulation of transcription by RNA polymerase II;11.0;0.5461734764479651;0.7055156905536448;8.363590748376499;1463.8556817380634;2.718315475161805;0.048993932283191266;0.5714437321440341;[CRTC2, ZNF175, CCNK, MAML1, CCNH, GFI1, ZNF292, ARID4A, RORA, YEATS4, UBE3A, IKZF1, PARK7, IKZF2, ELK1, YY1, RPS6KA4, RPS6KA5, MYC, STK16, DPF2, EP300, SOX8, SOX6, IER5, HMGN3, ZNF564, IER2, CDK5RAP3, DDX17, MEF2B, FLT3LG, MED6, RUNX2, PIAS2, RUNX1, ARMCX3, SFRP2, IL23A, TBL1XR1, RFX4, HOXB4, ATF4, PAXIP1, MAX, ZNF24, RLF, SUPT6H, BCL2L12, HSPH1, RAD21, HLTF, SCAP, NLRP3, HOXC4, ZBED1, RIPK1, CYTL1, PPARGC1B, TFAP2A, ZBTB17, ZNF143, DR1, CREBBP, XBP1, XRCC6, JUP, PBX3, EAF2, ERLIN2, FLI1, NFKB1, SETX, CDK9, NFKBIA, NR4A2, BCL9, CDK8, IL6, STAG1, TFCP2, COPS5, CNOT7, SP1, SP3, MAFF, BCL3, MNAT1, NFE2L1, ARF4, CIITA, CD40, SETD3, BMPR2, ONECUT2, ELL, THRA, CHD8, CHD7, DDX41, HOXC13, BRCA1, LDB2, AATF, PKD2, HOXC10, MED12, FLCN, NIPBL, SIN3A, HYAL2, MLX, HRAS, TEAD2, ZNF485, MKL2, KLF10, KLF13, RBM15, PPP1R12A, PEG3, NCOA6, MKL1, ARNT, SENP2, SAFB, TMEM173, PPRC1, SIRT2, GNL3, CREB3, GAL, TFDP1, RBL1, TFDP2, ELF4, IRF4, THRAP3, MTF2, TFEC, RARA, EAPP, MET, HDAC3, ZNF350, HDAC1, WBP2, CEBPE, CEBPG, GPS2, RELA, ARNTL, RXRA, PLAGL2, MTA2, E2F7, E2F8, TBX1, ZNF462, TCF7L2, NFYC, ATAD2, CDC5L, ARID3B, GRHL1, USF2, POMC, KLF6, NFIA, TNIP1, NFIB, TNIP2, TTC5, NFIC, PSMC1, ASXL2, TAF7, CAMK1, TAF4, SSBP3, MIXL1]
GO:0043525;positive regulation of neuron apoptotic process;8.0;0.8436909121759173;0.7968454560879586;9.392135474427892;179.36331192335928;5.885253329569843;0.0060031286335741505;0.6759721289664703;[TFAP2A, PRNP, CDK5, CASP3, CCL3, CASP2, BAX, ATF4]
GO:0043524;negative regulation of neuron apoptotic process;8.0;0.7866048967936545;0.7683024483968273;9.245532000236016;179.62959498689688;4.864418741944418;0.006012040888071555;0.6237666006816429;[BTG2, ANGPT1, WFS1, BDNF, NONO, KIF14, PARK7, CORO1A, SOD1, NR4A2, CLN3, ADORA2A, CCL2, BAX, KRAS, HYOU1, ADNP, SNCB, HRAS, CPEB4]
GO:0050850;positive regulation of calcium-mediated signaling;8.0;0.7763722522362496;0.7631861261181248;9.283683766200392;239.92176968958296;6.039404009397101;0.008029965715936047;0.6838554019015759;[PTBP1, CD4, P2RX5, P2RX4, SYK, CCL3, CIB1, CALM3, CALM1, PKD2, CALM2]
GO:0070584;mitochondrion morphogenesis;5.0;1.0;0.7902410118609202;9.628524252492122;64.70445744698846;6.781341354126479;0.002165599960519628;0.6370391240755715;[PNPT1, NDUFS6, NUBPL, OPA3, BAX, MTM1]
GO:0001649;osteoblast differentiation;4.0;1.0;0.75;9.628524252492122;21.066225782797595;5.171903441692378;7.050676185779127E-4;0.5144913825262545;[IGFBP5, H3F3A, HSD17B4, RRBP1, HSPE1, SND1, RUNX2, RPS15, SFRP1, TP53INP2, CAT, TMEM119, CCL3, SOX8]
GO:0033599;regulation of mammary gland epithelial cell proliferation;6.0;0.8653626801206646;0.7558016526504768;9.34084218004034;45.58987593597882;6.8867018697843045;0.0015258521193526465;0.6753065664753021;[BAX]
GO:0030521;androgen receptor signaling pathway;8.0;0.8933024483968273;0.8216512241984136;9.446202695698167;54.01143535742291;5.948432231191374;0.0018077141342769656;0.6792031009335148;[DDX17, MED12, MED30, CCNE1, THRAP3, UBE3A, BRCA1, ARID1A, FKBP4, PIAS2]
GO:0010595;positive regulation of endothelial cell migration;9.0;0.8259837884571596;0.8092325194088689;9.488762310116963;298.6320589889849;5.2552850506314295;0.009994946262957053;0.664996147065328;[MAP3K3, SCARB1, GPI, CD40, BMPR2, ANXA1, ANGPT1, ROCK2, ITGB3, PDCD6, CIB1, THBS1, RHOB, P2RX4, SP1, TMSB4X, ABL1, TEK, MET, AAMP, SASH1]
GO:0050731;positive regulation of peptidyl-tyrosine phosphorylation;10.0;0.7866048967936545;0.8085434602577476;9.446202695698167;779.3603785568229;4.60092389510664;0.02608449049149353;0.6505324738215158;[CD40, NCF1, ITGB3, CD80, LRP8, HSPH1, CCL5, ABL1, IL12A, PRNP, CD74, ANGPT1, SEMA4D, SYK, BDNF, ADRA2C, CD4, IL6, EHD4, ARL2BP, IL23A, KIT, ADNP, CD24, HBEGF]
GO:0016579;protein deubiquitination;9.0;0.7307253602413294;0.7616033053009538;9.151600180401813;202.59641706362558;4.174954806800768;0.0067807197541817285;0.6097480081553338;[USP36, USP37, WDR48, USP38, USP32, USP34, PTEN, OTUD7B, BRCA1, USP39, YY1, PSMD8, POLB, PSMD7, PSMD4, PSMD2, MYC, SKP2, ATXN7L3, USP46, USP8, RAD23A, JOSD1, CDC25A, TGFBR1, PSMA1, PSME2, USP41, BIRC3, USP13, BECN1, USP12, WDR20, NEDD8, PSMB10, PSMA7, VCPIP1, TFPT, RHOT1, PSMB5, PSMB1, NLRP3, USP51, RIPK1, MBD6, NFKBIA, CYLD, COPS5, TNIP1, TNIP2, PSMC1, ASXL2, OTUD1]
GO:0007084;mitotic nuclear envelope reassembly;6.0;1.0;0.8231203125901445;9.628524252492122;35.641415366952565;7.8311634786251565;0.0011928860971405699;0.7236063770733796;[LMNA, VRK1, BANF1, EMD]
GO:0090166;Golgi disassembly;5.0;1.0;0.7902410118609202;9.628524252492122;58.9131161342151;7.9853141584524145;0.001971768978649902;0.6986103492792611;[STX5, VRK1]
GO:0000209;protein polyubiquitination;10.0;0.7671156992804218;0.7987988615011312;9.223059144383958;155.4032479663248;4.243684138952949;0.005201206855589802;0.6322632160784685;[ANAPC13, CCNF, UBE2D3, UBE3A, BRCA1, FBXO41, ANAPC11, UBE2L3, NPEPPS, FZR1, ZNRF2, RNF213, RNF138, CDC26, UBR5, TRIM69, LONRF3, TRIM27, RFFL, SKP2, C18orf25, SASH1, RNF20, MYLIP, UBE2B, DTX3L, FBXW11, UBE2E3, SYVN1, ZFP91, UBE4A, FBXL15, LNPEP, FBXL16, MARCH6, RC3H2, ITCH, SPSB1, UBE2T, CDC16, FBXL3, ANAPC5, TRIM32, THOP1, RNF166]
GO:0008053;mitochondrial fusion;5.0;0.9326813400603323;0.7565816818910864;9.523163736834295;60.85147907762772;6.943860283624253;0.0020366442419525303;0.6453503496879909;[STOML2, MFN2, BAX, GDAP1]
GO:1901653;cellular response to peptide;6.0;0.6913464685778243;0.6687935468790567;8.798175950418692;225.6348642598113;4.473768719621393;0.007551795848581705;0.5519090529631041;[ERRFI1, MAX, ADCY4, PTEN, PTPN22, AGER, CRHR1, RELA, IGF1R, RAP1B, PPAT, CSK, RAB8B, WDTC1, PCK2, KLF10, PRNP, KLF11, XBP1, CAV1, PRKCD, CDC5L, TSHR, NFKB1, NR4A2, CDK5, SP1, MARS, RAB13, TIMELESS, TRIB3]
GO:0060416;response to growth hormone;7.0;0.9326813400603323;0.8172600352873667;9.541512875502493;74.03337757263446;7.138016298065211;0.0024778305216419678;0.7159578506919597;[PNPT1, IGFBP5, CACYBP]
GO:0043653;mitochondrial fragmentation involved in apoptotic process;6.0;1.0;0.8231203125901445;9.628524252492122;22.134985108306864;7.474488534686424;7.408380313817617E-4;0.7053660038532718;[BAX]
GO:0009267;cellular response to starvation;6.0;0.6369964171292115;0.6416185211547503;8.460919092337061;112.76702064936369;4.807260328104469;0.0037742106974044997;0.5689638293298743;[PLEKHF2, KLF10, BECN1, GABARAPL1, CDKN1A, XBP1, SEH1L, BMPR2, MAX, CLEC16A, EIF2AK3, COMT, EIF2S1, SFRP1, WRN, TBL2, MARS, LAMP2, PIK3C3, FADS1, CPEB4, ATG5, MAP3K5, ATF4]
GO:0051281;positive regulation of release of sequestered calcium ion into cytosol;13.0;0.8933024483968273;0.9092061889660501;9.585964638073326;905.0686146861244;6.139487467954083;0.03029183202467376;0.7765286393941734;[CXCL9, CXCL11, ABL1, BAX, CALM3, CALM1, PKD2, CALM2, NTSR1]
GO:0001782;B cell homeostasis;7.0;0.9326813400603323;0.8172600352873667;9.510741216835738;22.00128503895464;6.599019797332524;7.363632103827933E-4;0.6883935445785896;[DOCK11, CASP3, ABL1, BAX, NCKAP1L, RC3H2]
GO:0090280;positive regulation of calcium ion import;9.0;0.8653626801206646;0.8289219652406215;9.420884887713877;92.69484377077161;6.8867018697843045;0.0031024130010644134;0.7484268790654467;[PDGFRB, CCL3, CCL2]
GO:0001541;ovarian follicle development;4.0;1.0;0.75;9.628524252492122;34.608406302298;6.166155715036245;0.001158312213394382;0.5653374900225189;[EIF2B4, KIT, BAX, UBE3A, TAF4, SOD1]
GO:2000427;positive regulation of apoptotic cell clearance;9.0;0.9326813400603323;0.8625812952104552;9.571365838652174;227.08343208129315;7.8311634786251565;0.007600278109940302;0.7967266896635242;[C3, CCL2, CD300LF, C2]
GO:1990830;cellular response to leukemia inhibitory factor;6.0;1.0;0.8231203125901445;9.628524252492122;81.6500655361772;5.266214121163619;0.0027327542132076126;0.5924347476504533;[TLE4, XBP1, TFRC, PMM1, XRCC5, EED, CACYBP, BSPRY, SRM, BCLAF1, RNF138, PIGA, MTF2, ADAM23, JARID2, NEFH]
GO:0001777;T cell homeostatic proliferation;7.0;1.0;0.8509193652572005;9.628524252492122;53.24038617789342;9.777073627680469;0.0017819078121373234;0.8509193652572005;[BAX]
GO:0045046;protein import into peroxisome membrane;11.0;1.0;0.9324289523296623;9.628524252492122;483.1421344216107;7.9853141584524145;0.01617033243939992;0.8407982897480031;[PEX16, PEX19, RAB8B, PEX26]
GO:0010248;establishment or maintenance of transmembrane electrochemical gradient;6.0;1.0;0.8231203125901445;9.628524252492122;27.942148572769092;7.212124270218933;9.351985664295021E-4;0.6919486831672181;[BAX, ATP1B2]
GO:1901385;regulation of voltage-gated calcium channel activity;10.0;0.811012628672052;0.8207473261969463;9.474373572664863;230.24677907309362;6.139487467954083;0.007706152486928402;0.7292146864874571;[AHNAK, KCNE3, NPPA, CRHR1]
GO:0006120;mitochondrial electron transport, NADH to ubiquinone;6.0;1.0;0.8231203125901445;9.628524252492122;32.64917349834284;5.9928839937622085;0.0010927384546410499;0.6295966787287501;[NDUFA7, NDUFB7, NDUFS8, NDUFB10, NDUFS7, NDUFS6, NDUFA10, COQ9, NDUFV3]
GO:0046655;folic acid metabolic process;7.0;0.8933024483968273;0.7975705894556142;9.551563211355994;318.75190525379287;6.7325511899570465;0.010668339410754122;0.6952223462072524;[MTHFD1L, MTHFD1, MTHFD2L, FOLR2, ALDH1L2]
GO:0006366;transcription by RNA polymerase II;10.0;0.6039883530135606;0.7172351883677006;8.613793447804714;583.8786478812184;3.2909128387363804;0.01954189288791682;0.5835384474769965;[TCERG1, ZNF175, CCNK, CCNH, ZNF292, ARID4A, ELK1, MYC, STK16, TRIM24, EP300, IER2, GTF2I, MEF2B, ZBTB32, RUNX1, RFX4, ATF4, MAX, RPAP1, ZNF24, SUPT6H, GTF2E2, RAD21, HLTF, HIVEP1, HOXC4, ZBED1, HIVEP2, TFAP2A, ZBTB17, ZNF143, XBP1, INTS3, PBX3, EAF2, NFXL1, FLI1, NFKB1, CDK9, STAG1, TFCP2, COPS5, SP1, MAFF, NFE2L3, INTS4, INTS7, INTS6, MNAT1, ZNF136, INTS8, NFE2L1, BMPR2, ONECUT2, ELL, THRA, INTS10, HOXC13, BRCA1, AFF4, HOXC10, HYAL2, ZNF768, MKL2, KLF10, KLF11, TBP, KLF13, MKL1, ARNT, CREB3, NCOR1, TFDP1, TFDP2, ELF4, IRF4, NFX1, TFEC, MED20, ZNF516, LCOR, WBP2, CEBPE, CEBPG, RELA, ARNTL, POLR2B, TAF1A, POLR2E, PLAGL2, POLR2G, POLR2I, POLR2K, TCFL5, POLR2J3, TAF15, NFYC, CDC5L, ARID3B, DEK, GRHL1, USF2, GTF2H4, GFI1B, KLF6, NFIA, NFIB, NFIC, TAF7, TAF5, TAF4, SSBP3, MIXL1]
GO:0006364;rRNA processing;9.0;0.6347111282356054;0.7135961892980918;8.681142933547935;356.38664419027253;4.478756261132433;0.01192794025389202;0.6252844286580675;[DDX27, POP4, SUV39H1, EIF4A3, HEATR1, CHD7, ISG20L2, NOLC1, NAT10, NOL9, NOC4L, WDR43, RRP9, NOL6, RPS15, PES1, EXOSC3, DDX17, RPS9, WDR37, RPS7, DIS3, WDR18, IMP4, RPSA, BYSL, BOP1, LAS1L, RPL7L1, MRTO4, XRN2]
GO:0032091;negative regulation of protein binding;5.0;0.6997970393407541;0.6401395315312973;8.48339194818912;32.716075545242866;5.171903441692378;0.0010949776059428606;0.5547323943871747;[LRPAP1, CAV1, PRKCD, TFIP11, PARK7, SENP2, EIF2S1, AES, PPP1CA, GNL3L, BAX, CAMK1, ADNP, DISC1, MET, DACT1]
GO:0006367;transcription initiation from RNA polymerase II promoter;9.0;1.0;0.896240625180289;9.628524252492122;477.15162764714074;4.629579150867016;0.015969835568764485;0.6329975182530758;[CDKN1A, THRA, MAML1, CCNH, RORA, ZNF45, GTF2E2, MED12, RXRA, MED30, POLR2B, NPPA, POLR2E, POLR2G, POLR2I, TEAD2, POLR2K, GTF2I, CREBBP, TBP, TAF15, GTF2H4, MED6, RUNX2, CDK9, NR4A2, CDK8, THRAP3, MED20, RARA, TAF7, BAX, TAF5, MNAT1, TAF4]
GO:0072384;organelle transport along microtubule;7.0;0.6835726970475526;0.6927057137809769;8.935377071932177;89.05634386756805;5.514393750639154;0.0029806356837415084;0.6329257181104212;[MAP1S, KIF23, TRAK1, BICD1, AP3M1, ARHGAP21, CLN3, RHOT2, SPAST, RHOT1, KIF3B, BLOC1S1, AP3S2, COPG2, RAB6A, PAFAH1B1]
GO:0000381;regulation of alternative mRNA splicing, via spliceosome;10.0;1.0;0.9152410118609203;9.628524252492122;185.80693659341267;5.649939242635378;0.00621879095239513;0.704179167478338;[DDX17, PTBP1, MBNL1, WTAP, THRAP3, SAP18, RBM5]
GO:0043030;regulation of macrophage activation;6.0;0.8259837884571596;0.7361122068187242;9.377209824211215;27.112248267214866;6.088194173566533;9.074225500643868E-4;0.63447084575632;[CD74, IL4R, KARS, TNIP2, ITGB2, RORA, THBS1, AGER, CD200, HAVCR2]
GO:0043153;entrainment of circadian clock by photoperiod;6.0;1.0;0.8231203125901445;9.628524252492122;32.762264927729;6.686031174322154;0.001096523523006926;0.665044257777226;[PPP1CB, PER2, PPP1CC, FBXL3, PPP1CA]
GO:0016055;Wnt signaling pathway;7.0;0.5916390046238794;0.6467388675691402;7.647522783625538;28.581916314885376;4.0633408221711;9.566110170045473E-4;0.558718803867703;[VPS29, CHD8, USP34, PTEN, KLHL12, VPS26A, PRICKLE1, APCDD1, MED12, GNG2, GNAT2, RNF138, MYC, GRK6, AP2S1, SPIN1, DVL3, DISC1, GPC6, MARK2, DACT1, TLE4, TCF7L2, CSNK2A1, UBE2B, RYK, FBXW11, FZD6, SENP2, AES, DDB1, NR4A2, CYLD, BCL9, SFRP1, SFRP2, CCNE1, SDC1, TAX1BP3, CALM1, CD24, MET, CSNK1G2, TNRC6A, CSNK1G1, TNRC6B]
GO:0032760;positive regulation of tumor necrosis factor production;7.0;0.8933024483968273;0.7975705894556142;9.461470167828956;85.9095484537234;5.587418885654044;0.002875315273172136;0.6366602269110988;[ARFGEF2, FCER1G, IL23A, CCL3, ZBTB20, RIPK1, CCL19, THBS1, CCR2, HAVCR2]
GO:0055007;cardiac muscle cell differentiation;6.0;0.7866048967936545;0.7164227609869718;9.0689084645567;45.916641199513585;6.409777797693995;0.0015367886586535107;0.6509166472493662;[ITGB1, AKAP13, RXRA, RARA, CACYBP, ARID1A, SOX6]
GO:0048280;vesicle fusion with Golgi apparatus;7.0;0.811012628672052;0.7564256795932265;9.193206181234276;65.8060249050737;7.379178354882098;0.0022024684319953925;0.728290889492758;[STX5, SEC22C]
GO:0042987;amyloid precursor protein catabolic process;6.0;0.9326813400603323;0.7894609826203107;9.523163736834295;48.551292581453126;7.57984905034425;0.0016249680693747237;0.710754145523778;[CLN3, PSEN2]
GO:0035234;ectopic germ cell programmed cell death;5.0;1.0;0.7902410118609202;9.628524252492122;49.330608194382684;7.9853141584524145;0.001651051061600959;0.6986103492792611;[KIT, CASP2, BAX]
GO:1901030;positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway;9.0;0.9326813400603323;0.8625812952104552;9.604993755081928;568.8852724275073;6.311337724880743;0.01904007810464297;0.7190027299379095;[TFDP1, CASP8, TFDP2, YWHAB, ATPIF1, TP53BP2, BAX, BID, YWHAZ, BBC3]
GO:0007220;Notch receptor processing;6.0;1.0;0.8231203125901445;9.628524252492122;83.35257022185557;7.379178354882098;0.0027897355128825266;0.7004918368257019;[GALNT11, PSEN2]
GO:0090023;positive regulation of neutrophil chemotaxis;11.0;1.0;0.9324289523296623;9.628524252492122;945.710466239641;6.343086423195323;0.03165207822087823;0.7568146869955557;[CXCL6, CD74, IL23A, C1QBP, NCKAP1L, CCL19]
GO:0046666;retinal cell programmed cell death;5.0;0.9326813400603323;0.7565816818910864;9.4949928598676;29.711636272016438;9.083926447120524;9.944217272877711E-4;0.7547934328124444;[BAX]
GO:1905515;non-motile cilium assembly;7.0;1.0;0.8509193652572005;9.628524252492122;138.7811185870196;6.039404009397101;0.004644879144209681;0.6597747671587765;[BBS2, CENPJ, TMEM107, MKS1, IFT122, DISC1]
GO:0007342;fusion of sperm to egg plasma membrane involved in single fertilization;6.0;1.0;0.8231203125901445;9.628524252492122;41.84633322739465;7.004484905440688;0.0014005591138660403;0.6813299963962409;[CD9, FOLR2]
GO:1900745;positive regulation of p38MAPK cascade;12.0;1.0;0.9481203125901445;9.628524252492122;1761.632567075866;6.7325511899570465;0.05896025665364957;0.7924232935401965;[MAP3K3, KARS, NCF1, AGER, SASH1, MAP3K5]
GO:0010629;negative regulation of gene expression;6.0;0.471430776349301;0.558835700764795;6.738152494595957;59.04642522059629;2.349334787147576;0.001976230713800692;0.44326540286011196;[TCERG1, ZNF175, RPL3, RNH1, GFI1, EIF4A3, PPP2R2A, IKZF1, IKZF2, RPS15, RPS6KA5, MYC, SAP130, DPF2, TRIM24, CPNE1, SOX8, DIP2A, TRIM27, SOX6, DDX17, ZNF282, SLC35C2, SFMBT2, SERPINF1, ZNF12, HCFC2, SND1, RUNX2, THAP1, RUNX1, EID1, SFRP1, SFRP2, XRN1, HOXB4, TRIB3, RPL29, ATF4, FOXG1, MEPCE, ZNF24, GLG1, MTDH, FXR1, DHX34, HIVEP1, HESX1, A2M, PPARGC1B, BBS2, CREBBP, XRCC6, ZNF263, XRCC5, BCL11A, H3F3A, EIF2AK3, UPF3A, QARS, PKIA, DCP1A, RCOR3, ZNF136, EZH2, CPEB4, CC2D1B, CDKN1C, HBS1L, BTG2, CDKN1A, SMG1, TCF25, SUV39H1, OTUD7B, BRCA1, PTPRK, SMG5, NIPBL, C1QBP, MLX, CIC, JARID2, HRAS, HAVCR2, UPF2, ZNF485, UPF1, TSC22D4, HELLS, HBZ, TSC22D3, SIRT7, PPHLN1, SIRT2, NME1, AES, NCOR2, NCOR1, NFX1, PTRH2, CSDE1, MTF2, DEPDC1, RARA, DCP2, ZNF350, GPS2, PRICKLE1, RELA, ARNTL, PPP2CA, BCLAF1, RXRA, EXOSC3, DCPS, RPL19, YTHDF3, NFYC, PER2, CENPF, GFI1B, HIST3H2A, NFIA, NFIB, NFIC, LIMS1, NAB1, GMNN, UBE2D3, ARID4A, UBP1, ZBTB20, CASC3, PARK7, UBE2Z, YY1, EIF4ENIF1, PAIP2B, WWC3, EP300, ZNF564, TLE4, RPS9, IGFBP5, RPS7, FBXW11, ZBTB32, SARS, RPSA, RNF40, ERN1, OLFM1, ILF3, BRMS1, ZNF93, TBL1XR1, PSPC1, CCNE1, MRTO4, TIMELESS, MYADM, ADNP, PPID, MAX, SUPT6H, BCL2L12, CCNB1, NLRP7, BAG3, TPR, SUDS3, BPTF, WDTC1, TFAP2A, PRNP, DR1, UBE2I, PNPT1, CBX4, WFS1, CBX3, NONO, CAV1, NFXL1, CNOT10, HELZ, LSM5, EIF2S1, NFKB1, CDK9, CNOT4, NR4A2, CNOT6, PAN3, CNOT7, CDK5, YEATS2, CNOT1, CAPRIN1, SP3, BCL3, CNOT3, CDK2, ZNF658, NFE2L3, SKIV2L, CNOT8, PHF19, PICALM, USP36, CIITA, PIWIL4, THRA, YWHAB, CHD8, PTPN22, LDB2, FLCN, PTBP1, SIN3A, LRRFIP1, HIF1AN, DACT1, KLF10, KLF11, KLF12, PEG3, RFC1, H2AFY, EED, DIS3, PAPD4, ARID1A, ZFP90, DUSP22, RBL1, TFDP2, THRAP3, LCOR, ETF1, BIRC6, EIF4E2, EAPP, GAPDH, MCPH1, BIRC3, HDAC3, HDAC1, NLRC4, CXXC5, LRP8, THBS1, DNAJB1, U2AF2, DNAJB5, TP53INP1, CCL3, SAP18, POLR2G, RBBP7, MTA2, E2F6, E2F7, ZNF189, E2F8, TCFL5, IRX1, RNF20, SPEN, TCF7L2, SEMA4D, RPL23A, PNRC1, PNRC2, TAF7, TNRC6A, TRIM33, TNRC6B]
GO:0045581;negative regulation of T cell differentiation;9.0;0.7043150770688792;0.7483981637147287;9.320222892837606;878.9850552837634;6.088194173566533;0.029418838765156156;0.7075911583464645;[CYLD, CD74, IL4R, ANXA1, CTLA4, RC3H2, RUNX1]
GO:0031668;cellular response to extracellular stimulus;4.0;0.5452700253111464;0.5226350126555732;7.377232453885626;45.163559484697416;4.334655917158676;0.0015115836913881548;0.47167450518560927;[PLEKHF2, BECN1, CDKN1A, SEH1L, BMPR2, MAX, ABCB4, CLEC16A, COMT, AQP3, HSP90B1, WRN, LAMP2, NUDT15, SKP2, FADS1, ATG5, MAP3K5, KLF10, GABARAPL1, XBP1, EIF2AK3, USF2, EIF2S1, GDAP1, SSH1, SOD1, AES, P2RX7, NR4A2, SFRP1, TBL2, P2RX4, SFRP2, MARS, PIK3C3, ULK1, ADNP, FOLR2, CPEB4, ATF4]
GO:0007219;Notch signaling pathway;6.0;0.7763722522362496;0.7113064387082693;8.866384200445225;26.50247477320489;4.99795013456894;8.87013979980389E-4;0.5787157149004503;[SPEN, GALNT11, ITCH, CREBBP, MAML1, PERP, MYC, NOTCH2NL, PSEN2, EP300, DTX2, MIB1]
GO:0010628;positive regulation of gene expression;6.0;0.4705935272257725;0.5584170762030307;6.666693530613812;58.797024432214236;2.2471302570788807;0.001967883493859682;0.43803865843940215;[ZNF175, CCNK, MAML1, CCNH, GFI1, ZNF292, EIF4A3, IKZF1, GPATCH3, IKZF2, ELK1, RPS6KA4, RPS6KA5, MYC, ZXDC, DPF2, TRIM24, SOX8, SOX6, IER5, ATXN7L3, IER2, CDK5RAP3, DDX17, MEF2B, SECISBP2, FLT3LG, PRKAB1, MED6, RUNX2, RUNX1, SFRP1, SFRP2, KARS, IL23A, RFX4, HOXB4, ATF4, PAXIP1, NOLC1, ZNF24, C3, FXR1, HSPH1, DHX34, RAD21, HLTF, SCAP, HOXC4, ZBED1, PPARGC1B, ZNF143, CREBBP, XBP1, XRCC6, JUP, PBX3, EIF2AK3, EAF2, UPF3A, ERLIN2, FLI1, SETX, STAG1, CDKN1C, ARF4, CD40, SETD3, ELL, HOXC13, BRCA1, AATF, WDR43, HOXC10, MED12, NIPBL, ING2, C1QBP, HYAL2, SH3PXD2B, MLX, SPIN1, TMED2, CTSH, HRAS, TEAD2, ZNF485, SEC13, NCOA6, SERPINB9, SIRT7, TMEM173, PPRC1, SIRT2, GNL3, NCOR2, GAL, NCOR1, MTF2, TFEC, KIT, RARA, MAPRE3, CDC123, ZNF350, HEATR1, GPS2, RELA, ARNTL, SERTAD3, BCLAF1, RXRA, SERTAD2, LMNA, PLAGL2, GPBP1L1, SF3B1, ZNF462, CD74, GSN, YTHDF3, NFYC, ATAD2, GRHL1, NFIA, NFIB, TTC5, NFIC, CAMK4, MARS, PSMC1, CAMK1, RAB3GAP1, MIXL1, LIMS1, CRTC2, NCF1, CD80, ARID4A, RORA, YEATS4, UBE3A, PARK7, YY1, STK16, EP300, HMGN3, ZNF564, MAP3K5, RPS9, RPS7, FBXW11, PIAS2, ERN1, ARMCX3, OLFM1, ILF3, TBL1XR1, CCNE1, MAX, RLF, SUPT6H, BCL2L12, CCNB1, MED30, UBR5, DVL3, NLRP3, RIPK1, CYTL1, BPTF, TFAP2A, ZBTB17, DR1, RHBDD1, CAV1, MSN, NFKB1, CDK9, NFKBIA, NR4A2, BCL9, CDK8, IL6, TFCP2, COPS5, CNOT7, SP1, SP3, MAFF, BCL3, CDK2, NFE2L3, MNAT1, IL7R, NFE2L1, PHF19, PICALM, CIITA, BMPR2, ONECUT2, THRA, CHD8, CHD7, PTEN, PTPN22, DDX41, LDB2, PKD2, CKS1B, RBM3, FLCN, LBH, SIN3A, NUP62, ARHGEF11, MKL2, KLF10, TBP, KLF13, RBM15, PPP1R12A, PEG3, DTX3L, RFC1, H2AFY, ITGA2, MKL1, ARNT, SENP2, SAFB, ARID1A, ZFP90, TGFBR1, DNM2, CREB3, TFDP1, RBL1, TFDP2, ELF4, IRF4, THRAP3, POLR1B, ZNF516, POLR1E, MYH9, EAPP, MET, PPP1R15A, HDAC3, HDAC1, WBP2, ROCK2, POLDIP3, CEBPE, CEBPG, THBS1, CLEC3B, U2AF2, TP53INP2, CCL5, TP53INP1, TAF1A, POLR2E, CCL3, POLR2G, PCBD1, MTA2, E2F7, POLR2K, E2F8, TBX1, RNF20, TCF7L2, CHURC1, TAF15, CDC5L, ARID3B, DEK, USF2, P2RX7, POMC, CD4, KLF6, TNIP1, TNIP2, ASXL2, TAF7, KRAS, FAM98A, TAF4, SSBP3]
GO:0045582;positive regulation of T cell differentiation;9.0;0.7043150770688792;0.7483981637147287;9.320222892837606;861.1600055729926;5.395046993006588;0.0288222503928399;0.6721435792979885;[CD74, XBP1, IL4R, ANXA1, CD83, SYK, CD80, RUNX1, ITPKB, CYLD, IL23A, NFKBIZ, RARA, NLRP3, NCKAP1L, IL12A, CCL19, IL12RB1, IL7R]
GO:0031663;lipopolysaccharide-mediated signaling pathway;6.0;1.0;0.8231203125901445;9.628524252492122;26.50247477320489;6.343086423195323;8.87013979980389E-4;0.647506047256038;[NFKBIA, SCARB1, CCL5, PRKCE, CCL3, CCL2, PTPN22, MTDH]
GO:0034498;early endosome to Golgi transport;7.0;1.0;0.8509193652572005;9.628524252492122;101.51493214272642;7.57984905034425;0.0033976134213095565;0.738553198190834;[STX5, RAB6A]
GO:0031666;positive regulation of lipopolysaccharide-mediated signaling pathway;7.0;1.0;0.8509193652572005;9.628524252492122;344.2408759115043;7.697632086000634;0.011521432320083432;0.7445766281117727;[SASH1]
GO:0060068;vagina development;6.0;1.0;0.8231203125901445;9.628524252492122;51.94554621050329;7.474488534686424;0.0017385706837090898;0.7053660038532718;[BAX]
GO:1902498;regulation of protein autoubiquitination;10.0;0.8933024483968273;0.861892236059334;9.4949928598676;79.97782052321757;8.390779266560578;0.0026767856775466578;0.8443458537639685;[SASH1]
GO:0009615;response to virus;5.0;0.7436939687323844;0.6620879962271125;8.801845679307654;27.267803904038782;4.174954806800768;9.126288572378991E-4;0.503748394835965;[BECN1, ZNF175, CD40, CXCL9, DDX41, ZC3HAV1, SAMHD1, LYST, RELA, CCL5, HYAL2, CFL1, NLRP3, IL12A, BANF1, CCL19, IFNAR2, DDX17, APOBEC3F, DTX3L, APOBEC3H, MX2, TMEM173, UNC13D, ITCH, ILF3, IL6, CDK6, CNOT7, GPAM, POLR3B, POLR3C, IL23A, BCL3, POLR3E, DDIT4, TLR7, SERINC3, LSM14A, APOBEC3A, XPR1, EXOC1]
GO:0042753;positive regulation of circadian rhythm;4.0;0.8259837884571596;0.6629918942285797;9.040737587590003;21.56673843117642;6.8867018697843045;7.21819326487013E-4;0.6021862538851576;[ADORA2A, FBXW11, THRAP3, RORA, ARNTL]
GO:0000122;negative regulation of transcription by RNA polymerase II;11.0;0.6073376606709605;0.7360977826651425;8.793202583151634;1836.9481969605868;3.0544438328250214;0.0614810030062249;0.5886333519864981;[TCERG1, ZNF175, GFI1, UBE2D3, ZBTB20, IKZF2, YY1, MYC, SAP130, WWC3, EP300, SOX8, TRIM27, SOX6, ZNF564, TLE4, ZBTB32, SARS, HCFC2, THAP1, RUNX1, EID1, BRMS1, TBL1XR1, CCNE1, HOXB4, TIMELESS, TRIB3, PPID, MAX, FOXG1, MEPCE, MTDH, BAG3, TPR, HIVEP1, HESX1, SUDS3, BPTF, WDTC1, TFAP2A, DR1, CREBBP, ZNF263, UBE2I, CBX4, WFS1, BCL11A, CAV1, NFXL1, NFKB1, NR4A2, CNOT7, YEATS2, CNOT1, PKIA, SP3, CDK2, NFE2L3, RCOR3, ZNF136, EZH2, CC2D1B, CIITA, BTG2, THRA, TCF25, SUV39H1, CHD8, OTUD7B, LDB2, FLCN, NIPBL, SIN3A, C1QBP, MLX, LRRFIP1, HIF1AN, CIC, JARID2, DACT1, KLF10, KLF11, HBZ, KLF12, PEG3, RFC1, H2AFY, EED, TSC22D3, SIRT7, ARID1A, SIRT2, ZFP90, AES, DUSP22, NCOR2, NCOR1, RBL1, NFX1, MTF2, RARA, LCOR, EAPP, MCPH1, HDAC3, ZNF350, HDAC1, GPS2, CXXC5, LRP8, RELA, DNAJB1, RXRA, DNAJB5, RBBP7, MTA2, E2F6, E2F7, ZNF189, E2F8, TCFL5, IRX1, SPEN, TCF7L2, SEMA4D, PER2, GFI1B, NFIA, NFIB, NFIC, TAF7, TRIM33]
GO:2000210;positive regulation of anoikis;8.0;1.0;0.875;9.628524252492122;103.81651994310933;7.8311634786251565;0.0034746454936938316;0.7754860644832351;[BRMS1, PTRH2, AES]
GO:0032981;mitochondrial respiratory chain complex I assembly;7.0;1.0;0.8509193652572005;9.628524252492122;91.11357555959822;5.618190544320798;0.003049489377085438;0.638233890966345;[NDUFA7, NDUFB7, NDUFA11, NDUFB10, NUBPL, NDUFA10, BCS1L, TAZ, FOXRED1, NDUFS8, NDUFS7, NDUFS6, NDUFV3]
GO:0043615;astrocyte cell migration;6.0;0.8933024483968273;0.7697715367885581;9.377209824211215;22.237500671838706;7.9853141584524145;7.442691350351552E-4;0.7314896500084853;[CCL3, CCL2, APCDD1]
GO:0035333;Notch receptor processing, ligand-dependent;8.0;1.0;0.875;9.628524252492122;50.748517158788495;7.8311634786251565;0.0016985071986044009;0.7754860644832351;[PSEN2]
GO:0060058;positive regulation of apoptotic process involved in mammary gland involution;10.0;1.0;0.9152410118609203;9.628524252492122;328.4316397121651;8.67846133901236;0.01099231141188041;0.8590579283277371;[BAX]
GO:0006351;transcription, DNA-templated;9.0;0.5708408884191841;0.6816610693898811;8.449869256150476;581.393741231429;1.9872050686257638;0.019458725298619164;0.49786638480429696;[TCERG1, ZNF175, CCNK, CCNH, GFI1, ZNF292, IKZF1, GPATCH3, IKZF2, ELK1, UBE2L3, MYC, SAP130, ZXDC, DPF2, TRIM24, CPNE1, SOX8, TRIM27, SOX6, IER5, ATXN7L3, IER2, DDX17, ZNF18, SAP30BP, MEF2B, CSNK2A1, ZNF282, RFX1, ZNF12, SND1, THAP1, RUNX1, EID1, EWSR1, RFX4, HOXB4, TRIB3, BCORL1, ASF1B, SF1, ATF4, ZNF276, ZNF395, ZNF274, ZNF394, PAXIP1, FOXG1, MYCBP2, ZNF20, CDCA7, ZNF23, RPAP1, ZNF24, ZNF25, COMMD9, RAD21, HLTF, HIVEP1, HESX1, HOXC4, ZBED1, HIVEP2, PPARGC1B, ZNF264, ZNF143, XBP1, XRCC6, ZNF263, SETDB1, ZNF260, XRCC5, BCL11A, INTS3, PBX3, EAF2, ZNF35, FLI1, SOX30, STAG1, ZNF30, ZNF813, INTS4, INTS7, INTS6, RCOR3, ZNF136, INTS8, EZH2, CC2D1B, PHF3, SETD5, BTG2, SETD3, ELL, ZNF250, TCF25, SUV39H1, INTS10, ATF7IP2, HOXC13, BRCA1, WASL, WDR43, HOXC10, NIPBL, CHAF1B, ING2, ZMYM2, SCML1, SCML4, C1QBP, HYAL2, MLX, SPIN1, CIC, JARID2, ZNF485, BRD3, TSC22D4, HELLS, COMMD3, BAZ1A, COMMD1, SIRT7, PPHLN1, PPRC1, ZFX, MED29, SIRT2, MED28, AES, NCOR2, NCOR1, NFX1, TFEC, MED20, DEPDC1, VGLL4, ZNF234, ZNF350, HEATR1, GPS2, ZNF2, ZNF69, RELA, ARNTL, SERTAD3, BCLAF1, SERTAD2, TCEAL3, PLAGL2, GPBP1L1, DEDD, ZNF101, ZNF585A, ZNF462, ZNF581, NFYC, ATAD2, GRHL1, GTF2H4, PER2, ZNF33A, GFI1B, NFIA, NFIB, NFIC, MARS, PKN2, ZNF213, ZNF696, MIXL1, ZNF212, ZNF331, CRTC2, NAB1, ARID4A, UBP1, ZBTB20, YEATS4, YY1, STK16, EP300, ZNF326, ZNF688, ZNF564, GTF2I, TLE4, ZNF441, ZNF561, ZNF680, ZBTB32, SARS, PIAS2, ERN1, ILF3, BRMS1, ZNF93, TBL1XR1, PSPC1, TIMELESS, ADNP, ZNF550, MAX, RLF, SUPT6H, GTF2E2, ZNF549, ZNF548, NLRP3, SUDS3, ZNF544, ZNF302, BPTF, TRAPPC2, TFAP2A, ZBTB17, DR1, CBX4, CBX3, NONO, NFXL1, CNOT10, NFKB1, CDK9, NR4A2, CNOT6, IRAK1BP1, TFCP2, COPS5, CNOT7, CNOT1, SP1, SP4, SP3, MAFF, BCL3, CNOT3, ZFP64, ZNF658, NFE2L3, ZNF777, ZNF655, CNOT8, TMEM18, MNAT1, ZNF654, BRWD1, ZNF532, ZNF410, NFE2L1, ZSCAN2, ZNF652, PHF19, NFKBIB, PHTF2, CIITA, BMPR2, ONECUT2, THRA, CHD9, CHD8, CDCA7L, CHD7, CHD1, AFF4, LBH, SIN3A, ZNF407, NUP62, NFKBIZ, ZNF768, ZNF525, ZNF524, ZNF766, LRRFIP1, HIF1AN, MKL2, KLF10, KLF11, KLF12, TBP, KLF13, RFC1, EED, BUD31, MKL1, ARNT, SAFB, ARID1A, ZFP90, CREB3, TFDP1, RBL1, ZNF519, TFDP2, ELF4, IRF4, POLR1B, ZNF638, ZNF516, LCOR, ZNF511, ZNF630, ITGB3BP, GTF3C1, SMARCD2, HDAC3, HDAC1, WBP2, CEBPE, CEBPG, CXXC5, TFPT, POLR2B, RBBP5, TP53INP2, FAM120B, TP53INP1, TAF1A, POLR2E, SAP18, POLR2G, PCBD1, ASCC3, RBBP7, POLR2I, E2F6, E2F7, POLR2K, ZNF189, E2F8, TCFL5, ZNF286A, TBX1, POLR2J3, SPEN, TCF7L2, CHURC1, TAF15, EYA2, CDC5L, ARID3B, DEK, USF2, PNRC1, MAPK13, PNRC2, KLF6, POLR3B, POLR3C, TNIP2, POLR3E, ASXL2, TAF7, MNDA, TAF5, TAF4, SSBP3, TRIM33]
GO:0035691;macrophage migration inhibitory factor signaling pathway;7.0;1.0;0.8509193652572005;9.628524252492122;30.19135422731818;9.777073627680469;0.00101047745553359;0.8509193652572005;[CD74]
GO:1904447;folate import across plasma membrane;11.0;1.0;0.9324289523296623;9.628524252492122;367.40217161022247;8.390779266560578;0.012296620043306694;0.8615337942327104;[FOLR2]
GO:0002792;negative regulation of peptide secretion;7.0;0.6181399273706679;0.6599893289425345;8.075175806709066;82.49507115094225;4.99795013456894;0.0027610357906781187;0.6065147675675062;[PTGER4, CD74, ANXA1, PPP1R11, ANGPT1, RHBDF2, IDH2, PTPN22, NLRP12, SFRP1, NLRP7, TMSB4X, NLRP3, TRIM27]
GO:0000132;establishment of mitotic spindle orientation;8.0;0.9326813400603323;0.8413406700301662;9.582004236857228;227.84740072539455;6.641579411751319;0.007625847452931234;0.7146506799819907;[NSFL1C, BCCIP, SPRY1, NDC80, PAFAH1B1, MCPH1]
GO:0009617;response to bacterium;5.0;0.7508913569872202;0.6656866903545304;8.935377071932177;27.267803904038782;3.9481280100702625;9.126288572378991E-4;0.49214846190264216;[ANKRD17, CXCL6, SEH1L, HIST1H2BJ, PPP1R11, CEBPE, DEFB1, IL27, NLRC4, WASL, LYST, NLRP3, CCL2, IL12A, HAVCR2, FGA, FCER1G, SYK, CCL20, CAV1, PRKCD, SERPINB9, RNASE3, VIL1, P2RX7, CD4, IL6, IL23A, BCL3, HIST1H2BC]
GO:0002548;monocyte chemotaxis;7.0;1.0;0.8509193652572005;9.628524252492122;125.46101547564297;6.039404009397101;0.004199067280386423;0.6597747671587765;[IL6, ANXA1, CCL3L1, CCL20, CCL5, CCL3, CCL2, CCL19, CCR2]
GO:0048873;homeostasis of number of cells within a tissue;6.0;0.8933024483968273;0.7697715367885581;9.377209824211215;26.75021374699733;6.444869117505266;8.953055804826206E-4;0.6527112189764278;[P2RX7, FLT3LG, VPS54, BAX, KRAS, CORO1A, CCR2]
GO:0070098;chemokine-mediated signaling pathway;7.0;0.7307253602413294;0.7162820453778652;8.999915593069748;30.19135422731818;5.459585514144159;0.00101047745553359;0.6301228223472235;[CXCL6, CXCL9, CXCL11, CCL3L1, CCL20, CCL5, CCL3, CCL2, CIB1, CCL19, CCR10, CCR2]
GO:0043066;negative regulation of apoptotic process;7.0;0.5640623033008358;0.6329505169076184;7.792313020693233;81.07407142393629;2.9735683700721314;0.0027134762086319553;0.5029877899877601;[CIB1, PARK7, UBE2Z, IGF1R, AQP1, MYC, CFL1, SOX8, EPHB4, IER3, PDGFRB, CSNK2A1, PRKCD, FLT3LG, THOC6, SFRP1, CFDP1, SFRP2, PPIF, VDAC2, ADNP, EPHA1, PPID, PSEN2, CORO1A, MTDH, HSP90B1, BCL2L12, BAG4, HSPH1, BAG3, BAG1, ABL1, NCKAP1L, RIPK1, NTSR1, ATG5, TFAP2A, PRNP, PRELID1, XBP1, UBE2B, CBX4, TNFSF14, WFS1, BDNF, NONO, RHBDD1, CAV1, TNFRSF10B, TNFRSF10A, NFKB1, SETX, VIL1, NFKBIA, NR4A2, IL6, SON, COPS5, QARS, BCL3, HYOU1, MNAT1, IL7R, CPEB4, AVEN, ITGB1, ARF4, BTG2, CDKN1A, DOCK8, TRADD, KIF14, PTEN, BRCA1, AATF, PIK3CG, ING2, CASP8, NNT, SIN3A, CASP3, NUP62, CASP2, CTSH, ITGAV, TIMP1, HRAS, TSC22D4, FGA, DFFA, FCER1G, ANXA1, SPHK2, SPHK1, TSC22D3, FGG, PLAUR, SERPINB9, YWHAZ, TGFBR1, DDB1, ITPKB, CREB3, ADORA2A, PTRH2, KIT, CAT, TMBIM1, RARA, BIRC6, MET, BIRC3, BECN1, HDAC3, HDAC1, NLRC4, THBS1, RELA, UNG, CLN3, CCL5, LMNA, CCL2, CCL19, RFFL, SNCB, BID, TBX1, CDKN2D, TCF7L2, CD74, ANGPT1, SEMA4D, EYA2, RYK, SYVN1, SOD1, ITCH, GPAM, TNIP2, BAX, KRAS, ERCC5, PDCD1, TEK, CIAPIN1, TRIM32, MAD2L1]
GO:0070534;protein K63-linked ubiquitination;11.0;0.9326813400603323;0.8987696223598284;9.577230958104572;157.60047254366168;6.166155715036245;0.00527474598481953;0.747766442352181;[ITCH, UBE2B, UBE2T, UBE2E3, ZFP91, TRIM27]
GO:2000343;positive regulation of chemokine (C-X-C motif) ligand 2 production;7.0;0.9326813400603323;0.8172600352873667;9.541512875502493;89.02652997090885;7.8311634786251565;0.0029796378394510905;0.7514054297404357;[CD74, MBP]
GO:0016024;CDP-diacylglycerol biosynthetic process;8.0;1.0;0.875;9.628524252492122;660.3044048651973;7.212124270218933;0.0220997941954548;0.7438283705770736;[AGPAT5, GPAM, AGPAT3]
GO:0030433;ubiquitin-dependent ERAD pathway;10.0;0.9326813400603323;0.8815816818910864;9.600353375525426;603.0491029665483;5.557565922504363;0.02018351076733335;0.6994551915910392;[SEC13, WFS1, EDEM1, DERL3, SYVN1, DERL2, UBE4A, ERLIN2, MARCH6, HSP90B1, RNF103, NPLOC4, PSMC1, UBQLN1, MAN1B1, RNF121]
GO:0032976;release of matrix enzymes from mitochondria;6.0;1.0;0.8231203125901445;9.628524252492122;22.134985108306864;9.777073627680469;7.408380313817617E-4;0.8231203125901445;[BAX]
